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 Summary 
Members of the Bifidobacterium genus are of common inhabitants of the gastro-intestinal tract 
(GIT) of mammals. Bifidobacteria are high G+C Gram-positive obligate anaerobes belonging to the 
Actinobacteria phylum. Of the 47 bifidobacterial so far identified taxa, 11 have been isolated from 
human GIT. Bifidobacteria are among the first colonizers of the sterile GITs of newborns and they 
predominate in breast-fed infants until weaning. After this phase Bacteroides and other groups 
become dominant. In fact, b ifidobacteria are not numerically dominant in the complex adult  
intestinal microflora, but they are considered as key commensals because they promote a healthy 
status in the host. For this reason bifidobacteria are often used as healthy components in functional 
foods. Recently numerous molecular approaches have emerged for the identification and 
characterizat ion of bifidobacterial strains . In this context, genomic-based efforts, i.e., 
probiogenomics, have helped us to understand the mechanism mediating the host -microbiota 
interaction and in which way the bifidobacteria adapt themselves to the gastro-intestinal tract of the 
host. 
In this thesis were investigated the molecular bases sustaining the interaction of bifidobacteria with 
the host as well as with the other commensals members of the human GIT through in vitro and in 
vivo tests. 
 
 
 
 
 
 
  
 Sommario  
I bifidobatteri sono tra i microrganismi maggiormente presenti nel tratto gastro-intestinale (GIT) dei 
mammiferi. Sono batteri anaerobi obbligati appartenenti al phylum degli Actinobacteria, Gram-
positivi ad alto contenuto di G+C nel genoma. Sono state identificate 47 taxa di bifidobatteri, 11 dei 
quali isolati dal GIT umano. Sono i primi colonizzatori del tratto gastro-intestinale dei neonati e 
predominano in quelli allattati al seno, invece dopo lo svezzamento sono in quantità minore rispetto 
a Bacteroides ed altri gruppi microbici. Infatti, i bifidobatteri anche se non sono numericamente 
dominanti nella complessa microflo ra intestinale degli adulti, sono considerati dei commensali 
importanti nel promuovere lo stato di salute dell’ospite e per questa ragione sono spesso usati come 
componenti salutari negli alimenti funzionali.  
Recentemente sono emersi numerosi approcci molecolari per l’identificazione e la cara tterizzazione 
di ceppi d i bifidobatteri. Studi basati sulla genomica (probiogenomica) hanno permesso di 
comprendere i meccanis mi che mediano l’interazione tra microrganismo e ospite e in che modo i 
bifidobatteri si adattano alla nicchia eco logica umana.  
In questa tesi sono stati studiati i meccanismi molecolari responsabili dell’interazione dei 
bifidobatteri con l’ospite e con gli altri commensali del GIT umano, utilizzando sia test in vitro che 
in vivo. 
1. Introduction 
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1.1 Gastro-intestinal microbiota 
The human body surfaces are home to complex microb ial communities lead ing to an over-
representation of microbial cells respect to mammalian’s cells. In fact, the health human 
organism can be said to be composed of over 10
14 
cells, of which only about 10% are animal cells  
(somatic and germ cells) (Gill, Pop et al. 2006). The vast majority of the microb ial cells in that 
mass reside in the gastrointestinal tract (GIT) (10 to 100 t rillion) (Gill, Pop et al. 2006). The 
human GIT is an extremely complex microbial ecosystem, this genome contains at least 100 
times as many genes as our own genome (Gill, Pop et al. 2006). The microbial component (also 
termed the microbiota) largely influence the human health (Kurokawa, Itoh et al. 2007). Our gut 
microbiota can be pictured as a microbial organ placed within a host organ , which is composed 
of different cell lineages with a capacity to communicate with one another and the host; it 
consumes, stores, and redistributes energy; it mediates physiologically important chemical 
transformations; and it can maintain and repair itself through self-replication (Backhed, Ley et al. 
2005). Our relat ionship with members of this microbiota is often described as commensal 
relationships (one partner benefits and the other is apparently unaffected) as opposed to 
mutualistic interactions (both partners experience increased fitness) (Backhed, Ley et al. 2005). 
However, our distal intestine is an anaerobic bioreactor that harbors the large majority of our GIT 
microorganis ms. In this ecosystem bacteria synthesize essential amino acids and vitamins and 
they are involved in the breakdown of indigestible components of the human diet, like 
polysaccharides that are recalcitrant to digestion by mammalian’s enzymes , including plant-
derived pectin, cellu lose, hemicellulose, and resistant starches (Backhed, Ley et al. 2005). Some 
gut microbial members are permanently established (mucosa adherent components), whereas 
others may represent transient gut microbiota members (Eckburg, Bik et al. 2005, Ley, Peterson 
et al. 2006, Turroni, Marchesi et al. 2009). Residents gut microbiota members are also known to 
constitute an autochthonous microbiota, often establishing symbiotic relationships with the 
human organism, while travelers members of the gut microbiota are forming an allochthonous 
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microbiota that ingested through the diet and/or they are derived from environmental 
contaminations (Turroni, Ribbera et  al. 2008). The adult human GIT contains members of all tree  
domains of life : Archaea, Eukarya and Bacteria . The main bacterial divisions that dominate the 
GIT encompass Firmicutes (46-60%), Proteobacteria (10-30%), Bacteroidetes and 
Actinobacteria (8-28%) (Turroni, Ribbera et al. 2008). The majority of GIT microbiota resides in 
colon, where their abundance reach 10
12
 cells/g of luminal content (Isolauri, Salminen et al. 
2004). Bacterial populations residing in the upper compartments of the human GIT (mouth, 
esophagus, stomach) are less variable and numerous. Despite the high species richness and inter-
individual variability of the intestinal microbiota, a limited number of bacterial phylotypes 
(groups of bacterial DNA sequences sharing more than an arbitrarily chosen level of similarity) is 
more prevalent amongst individuals and might therefore represent a shared phylogenetic core 
(Tap, Mondot et al. 2009, Qin, Li et al. 2010). However, an accurate estimat ion of the size of the 
phylogenetic core remains still undefined (Gerritsen, Smidt et al. 2011). About 70% of GIT 
microbiota is considered to be variable among individuals as well as within the identical host. 
The GIT microbiota diversity result as a consequence of strong host selection and host-microbe 
coevolution (Backhed, Ley et al. 2005). The structure and composition of the gut microbiota 
reflect natural selection (Backhed, Ley et al. 2005). At the microbial level it is due to the 
combined action of various mechanisms, e.g. horizontal gene transfer (HGT), gene duplication, 
gene decay and genome rearrangements (Snel, Bork et al. 2002, Kunin and Ouzounis 2003, 
Ventura, Canchaya et al. 2007). HGT represents the principal genetic mechanis m, implemented 
through the activities of bacteriophage, IS elements, transposons, conjugative plasmids, and 
DNA-mediated transformation (Ley, Peterson et al. 2006). Furthermore, observed vertical 
genome evolution can be attributed to mutations, deletions and chromosomal rearrangements 
(Giraud, Matic et al. 2001). On the other hand, composition of microbiota in various regions of 
GIT d iffers due to variable environmental condition (Backhed, Ding et al. 2004). As above 
mentioned it is well established that the gut microbiota composition is highly variable between 
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individuals, and it is also subject to considerable change throughout the lifetime of an individual. 
External factors shaping the human GIT microbiota include antibiotic therapy and diet (Palmer, 
Bik et al. 2007). Recent studies into the impact of antibiotics on the microbiota have focused on 
the emergence of resistant strains and their influence on the microbial community. Results have 
shown that short and long-term antibiotic therapy affect diversity and biomass of the intestinal 
microbiota, with microbial composition resilience remaining deficient for long time after the 
treatment (Perez-Cobas, Artacho et al. 2013). Moreover, the availability of carbohydrates that 
escape metabolis m and adsorption in the small intestine (e.g., plant polysaccharides) has a major 
inﬂuence on the microbiota that ultimately becomes established in the colon (Kaplan and Hutkins 
2000). 
                  
 
 
 
 
 
 
 
Fig. 1.1: Bacterial species present in the different regions of human gastrointestinal tract . 
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1.2 Bifidobacteria  
The genus Bifidobacterium, which is a member of the Bifidobacteriaceae family and 
subsequently belongs to the Actinobacteria phylum (Stackebrandt and Tindall 2000). 
Bifidobacteria are characterized to include Gram-positive microorganisms with a h igh G+C DNA 
content. They were first isolated from faeces of a breast-fed infant by Tissier in 1899, and then 
named Bacillus bifidus (Tissier 1900). However, because of their morphological and 
physiological features, which are similar to those of lactobacilli, they were classified as members 
of the genus Lactobacillus during a large part of the 20th century and only recently they have 
been recognized constituting a different genus. Currently, the genus Bifidobacterium is 
comprised of 47 different taxa recognized, all of which have been isolated from the GIT contents 
of mammals, birds, or insects (Ventura, Canchaya et al. 2007, Ventura, Turroni et al. 2009, 
Ventura M 2014). Furthermore , the genus Biﬁdobacterium includes three subspecies  lineages: i) 
Bifidobacterium animalis subsp. animalis and Bifidobacterium animalis subsp. lactis; ii) 
Bifidobacterium pseudolongum subsp. globosum and Bifidobacterium pseudolongum subsp. 
pseudolongum; iii) Bifidobacterium longum subsp. infantis, Bifidobacterium longum subsp. 
longum and Bifidobacterium longum subsp. suis species. Recently, three new species have been 
isolated from the bumblebee digestive tracts, i.e., Bifidobacterium actinocoloniiforme, 
Bifidobacterium bohemicum and Bifidobacterium bombi (Killer, Kopecny et al. 2009, Killer, 
Kopecny et al. 2010). The last species characterized are Bi fidobacterium kashiwanohense, 
isolated from healthy in fant faeces  (Morita, Nakano et al. 2011);  
Bifidobacterium reuteri, Bifidobacterium callitrichos, Bifidobacterium saguini, 
Bifidobacterium stellenboschense and Bifidobacterium biavatii were isolated from faeces of 
common marmoset (Callithrix jacchus) and red-handed tamarin (Saguinus midas) (Endo, 
Futagawa-Endo et al. 2012). Bi fidobacterium moukalabense isolated from the faeces of wild west 
lowland gorilla (Gorilla gorilla gorilla) in Gabon  (Tsuchida, Takahashi et al. 2013). In addition, 
two bifidobacterial taxa, i.e., Bifidobacterium crudilactis and Bifidobacterium mongoliense, were 
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isolated from raw milk cheeses (St Marcellin, Vercors area, France) (Delcenserie, Tamin iau et al. 
2013). Taking their different ecological niches into account and combining  this information with 
a comparat ive analysis of their 16S rRNA sequences, as well as with other housekeeping genes 
(clpC, dnaJ, xfp, dnaB, rpoC and purF), the various Bifidobacterium taxa can be clustered into 
six different phylogenetic groups  named Bifidobacterium adolescentis-, Bifidobacterium 
asteroides-, Bifidobacterium boum-, Bifidobacterium longum-, Bifidobacterium pullorum-, and 
Bifidobacterium pseudolongum-phylogenetic group (Ventura, Canchaya et al. 2007).  
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Fig. 1.2: Phylogenetic tree of the genus Bifidobacterium based on 16S rRNA gene sequences. 
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1.2.1 Bifidobacteria and gut microbiota development 
The neonatal GIT is sterile, and its  colonization occurs within the first few days of life (Guarner 
and Malagelada 2003). The development of the intestinal microbiota of infant is combined with 
maternal vaginal microbiota, but only within the first day after birth (Turroni, Ribbera et al. 
2008). Intestinal microbiota composition of infants delivered through Caesarean section is 
therefore different from that of infants born vaginally (F. Guarner 2003). Thus, initial bacterial 
colonizat ion is dependent on the microbial communit ies to which newborns are exposed. In 
vaginal deliveries, facultative anaerobes including members of the Streptococcus and Escherichia 
genera dominate during the ﬁrst days of postnatal life  (Bik, Eckburg et al. 2006, Turroni, Ribbera 
et al. 2008). The early gut microbiota of infants delivered by caesarean section are dominated by 
Klebsiella, Enterobacter, and Clostridium, in contrast to vaginally delivered in fants, which 
possess a microbiota with a high proportion of biﬁdobacteria (Hayashi, Sakamoto et al. 2002). 
Maternal milk may also serve as an inoculum for breast-feeding infants, and is presumed to play 
a crucial role in the establishment of a biﬁdobacteria-abundant infant gut microbiota before the 
weaning period (Palmer, Bik et al. 2007, Zilberstein, Quintanilha et al. 2007, Turroni, Ribbera et 
al. 2008). A consistent correlation has been observed between gut microbiota composition and 
type of feeding (i.e., human milk vs formula milk), with a higher abundance of biﬁdobacteria in  
breastfed infants as compared to those that are bottle-fed (Roediger 1980). In the case of breast-
fed infants 60-90% of the bacteria belong to genus Bifidobacterium, and at lesser extends 
Bacteroides and Lactobacillus (below 1%). 
The selective growth of biﬁdobacteria observed in breast -fed newborns has been attributed to 
oligosaccharides contained in human milk named Human Milk Oligosaccharides (HMOs) (see 
below) (Knol, Scholtens et al. 2005, Ward, Ninonuevo et al. 2006, Wada, Ando et al. 2008, 
Turroni, Foroni et al. 2011, Kim, An et al. 2013).  
Instead in the adult human gut microbiota members of the genera Bifidobacterium, Bacteroides, 
Clostridium and Eubacterium are barely detected (Backhed, Ley et al. 2005), in fact  
Lactobacillus, Escherichia, Enterobacter, Streptococcus or Klebsiella dominate.  
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1.2.2 Bifidobacterial ecology 
Bifidobacteria are generally host-animal-speciﬁc microorganisms and can be separated as 
“human group”, “animal group” and others (Ventura, van Sinderen et al. 2004). Many subspecies 
of the genus Bifidobacterium have been isolated from the GIT of humans (Trovatelli, Crocian i et 
al. 1974, Lauer 1990, Hoyles, Inganas et al. 2002) and other animals (Scardovi, Trovatelli et al. 
1979, Watabe, Benno et al. 1983, Biavati and Mattarelli 1991, Biavati, Mattarelli et al. 1991, 
Zhu, Li et al. 2003), milk products (Watanabe, Makino et al. 2009), blood and food (Ventura, 
Canchaya et al. 2007). Three species of bifidobacteria were also found in honeybees (Scardovi 
and Trovatelli 1969). In addition, Mrazek et al (Mrazek, St rosova et al. 2008) detected 
bifidobacteria through molecular techniques in other social insects, including wasps (Vespula 
vulgaris), hornets (Vespa crabro) and cockroaches (Nauphoeta cinerea) (Killer, Kopecny et al. 
2010), which was found to be distinct from the bifidobacterial populations identified in the 
hindgut of honeybees (Killer, Kopecny et al. 2011).  
1.3 Probiogenomic 
Despite its importance, the precise composition and activities of the human GIT microbiota is 
still not well defined. For this reason, an accurate analysis of the microbial consortium resid ing 
within these human body compartments is an essential step to understand how the various 
elements of the GIT microbiota interact and consequently affect the health status of the host 
(Neish 2009). Research in microbiology has remarkab ly changed during the last decades, largely 
due to the availability of novel whole-genome sequencing approaches. In fact, the decoding of 
the genome sequences of more than 4,000 bacteria, as currently present in the NCBI database 
(www.ncbi.nlm.nih.gov) has greatly advanced our understanding of bacterial biology. The initial 
microbial genomics efforts were mainly d irected toward decoding the genomes of pathogenic 
bacteria because of their impact on human well-being. The obtained genomic data have opened 
new avenues of research and even sparked the origin of a new genomics -based discipline, called  
pathogenomics, which aims to understand the genetic basis of bacterial pathogenesis  (Pallen and 
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Wren 2007). Recently, genome sequencing has also directed its interest toward food -related 
bacteria, intestinal commensals and probiotic bacteria. In 2009, a correspondingly novel 
discipline designated as probiogenomics was defined, which aims to provide insights into the 
diversity and evolution of commensal/probiotic bacteria and to reveal the molecular basis for 
their health-promoting activities  (Ventura, O'Flaherty et al. 2009). The public availability of full 
genome sequence data has significantly expanded our understanding of the biology of these 
microorganis ms and has generated an enormous amount of information on metabolic capabilities, 
genetics and phylogeny of these bacteria. 
1.3.1 Probiotics 
 Probiotics are non-pathogenic live microorganisms that are admin istered to alter the intestinal 
microbiota and confer a beneficial effect on health (Shanahan 2005). The term derived from 
Greek and meaning “for life”, emerged from observations early in the 19th century by Elie 
Metchnikoff, known as the “father of probiotics” who hypothesized that the long and healthy 
lives of Bulgarian peasants  were rooted in their consumption of fermented milks containing 
beneﬁcial Lactobacillus. In 2001, the Food and Agriculture Organization (FAO) established the 
deﬁnition for probiotics  as “Live microorganisms which when  admin istered in adequate amount 
confer a health beneﬁt on the host” (FAO/WHO, 2002). This definit ion implies that safety and 
efficacy must be demonstrated for each probiotic strain. No specific criteria for selecting new 
probiotics have been so far proposed, however general criteria that must be taken into account 
involve the capacity to adhere to the intestinal mucosa, antimicrobial production and the ability 
to tolerate acid and bile stress  (Collins, Thornton et al. 1998). There are accumulating evidences 
underpinning the capacity of probiotic strains to  exert one or more of the following positive 
activities such as anti-inflammatory immune-modulation, reduction of atopic disease symptoms, 
beneficially in fluencing the composition and activity of intestinal microbiota, prevention or 
suppression of bacterial infections, reduction of lactose intolerance, reduction of intestinal 
inflammat ion, production of specific short chain fatty acids, conjugated linoleic acids and 
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vitamins and alleviation of constipation (Goldin 1998, Ouwehand, Lagstrom et al. 2002, Saxelin, 
Tynkkynen et al. 2005). Although there are suggestive evidences for each of these functional 
claims, the molecular mechanis ms behind such probiotic activities remain largely unknown 
(Turroni, Ventura et al. 2014). The decoding of microbial genome sequences, i.e., microbial 
genomics, offers the possibility of accelerating research into the molecular mechanis ms followed  
by probiotic bacteria to establish themselves within the human body as well as to interact with 
the human host (Ventura, Turroni et al. 2012). Lactobacilli and bifidobacteria have tradit ionally  
been considered the most common probiotics candidates, together with nonpathogenic 
Escherichia coli, Saccharomyces boulardii (Kanauchi, Andoh et al. 2013).   
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1.4 Genomics of bifidobacteria 
Currently, the genus Bifidobacterium includes 47 taxa (Turroni, van Sinderen et al. 2011) which  
31 completely sequenced bifidobacterial genomes were publicly available (Schell, Karmirantzou 
et al. 2002, Lee, Karamychev et al. 2008, Sela, Chapman et al. 2008, Barrangou, Briczinski et al. 
2009, Kim, Jeong et al. 2009, Ventura, Turroni et al. 2009, Turron i, Bottacini et al. 2010, Hao, 
Huang et al. 2011, Zhurina, Zomer et al. 2011, Bottacini, Milani et al. 2012) with genome 
sequences of additional 35 strains still unfin ished (NCBI source). Notably, for a small number of 
cases such as B. bifidum, B. longum subsp longum, (Schell, Karmirantzou et al. 2002, Lee, 
Karamychev et al. 2008) B. animalis subsp. lactis (Barrangou, Briczinski et al. 2009, Kim, Jeong 
et al. 2009) two or more genome sequences are publicly availab le. Genomics data has 
significantly enhanced and will continue to improve our knowledge on the functionality of 
various Bifidobacterium taxa. Furthermore, the acquired genomic informat ion data has also 
provided clues as to how bifidobacteria have adapted to the GIT environment and how they 
interact with their host. Comparative genome investigations of bifidobacterial strains completely  
sequenced, have highlighted that bifidobacterial pan-genome consists of more than 5,000 genes 
(Bottacini, Medini et al. 2010, Ventura, Turroni et al. 2014). In addition, it was identified a set of 
genes shared by all sequenced Bifidobacterium species, which represents a presumed core 
genome, including 967 genes encoding for housekeeping functions (replication, transcription, 
translation, cell envelope biogenesis and signal transduction) and involved in carbohydrate 
metabolism (Bottacini, Medini et al. 2010). Furthermore, the above mentioned comparative 
genome analysis allowed the identification of the so called Truly Unique Genes (TUG), including 
genes present only in a reference bifidobacterial genome and absent in any other genome rang ing 
from 21 to 230. Most of these unique genes have unknown functions but probably are important 
for bifidobacterial persistence in the GIT such as the ability of these bacteria to interact with their 
natural environmental and other microorganism (Bottacini, Medin i et al. 2010). 
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1.5 Genetically manipulation of the genus Bifidobacterium 
In order to explo it the molecular strategy used by bifidobacteria to colonize and survive within 
the human body, valuable methods to genetically manipulate their genomes are needed. 
However, studies focusing on bifidobacteria at the molecular level would be hampered by the 
absence of an efficient transformation system (Rossi, Brigid i et al. 1996). Although the 
electroporation as an effective technique for introducing DNA into many types of eukaryotic and 
prokaryotic cells, has proven to be widely applicab le to genetically transform bacterial strains 
from several genera of lactic acid bacteria, like Lactococcus, Pediococcus, Lactobacillus, 
Enterococcus (Luchansky, Muriana et al. 1988, Cruz-Rodz and Gilmore 1990), corynebacteria 
and brevibacteria (Bonnassie, Burini et al. 1990, Na, Shen et al. 1995), the large majority of 
Bifidobacterium strains, have largely proved to be recalcitrant to acquire alien DNA (Argnani, 
Leer et al. 1996). In this context, bifidobacterial display variable efficiencies of transformat ion 
between strains, ranging between 2x10
2 
and 7x10
4
 /μg DNA (Matsumura, Takeuchi et al. 1997). 
Low transformation efficiency is a bottleneck for gene manipulation  (Sakaguchi, He et al. 2012). 
The observed differences in transformat ion efficiency among different strains of biﬁdobacteria 
may be attributed, at least in part, to restrict ion/modiﬁcat ion (R/M) systems, which are ubiquitous 
among prokaryotes and generally comprise a restriction endonuclease (REase) and a cognate 
methyltransferase (MTase) (Tock and Dryden 2005). R/M systems are believed to serve 
primarily as defensive instruments that protect prokaryotic cells against invading DNA such as 
promiscuous plasmids or infecting bacteriophage (Tock and Dryden 2005). The contribution of 
R/M systems in reducing or abolishing transformation with in bifidobacteria, also reduced the 
chances to create gene knockout mutants . Generally, the homologous recombination events occur 
with a very low frequency and a very high transformat ion efficiency (over 10
5
 CFU/μg plas mid  
DNA) is generally required in order to achieve successfully recombination events  (Suzuki and 
Yasui 2011). Recently, to the best of our knowledge, the ﬁrst reliable system for creating 
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insertion mutation in a member of the genus Biﬁdobacterium, was obtained for Bifidobacterium 
breve UCC2003 (O'Connell Motherway, O'Driscoll et al. 2009). 
1.6 Bifidobacteria and utilization of host glycans  
The genomic adaptation is obvious in many biﬁdobacterial genomes where over 8% of annotated 
genes encode enzymes involved in carbohydrate metabolism which may be derived from the diet 
but also from the host (Turroni, Foron i et al. 2011). As expected, the genomes of gut commensals 
also carry more genes involved in mucin degradation than genomes of microorganisms from 
other environments (Walker, Cerdeno-Tarraga et al. 2006). Mucins are such host-produced 
glycoproteins secreted by goblet cells in the intestine, and form the main glycoprotein component 
of the mucus layer covering the intestinal mucosa (Ruas-Madiedo, Gueimonde et al. 2008). 
Given the diversity and complexity of mucin structures found  within the gut (Podolsky 1985, 
Jensen, Kolarich et al. 2010), speciﬁc strategies for deconstructing these molecules must be 
inherent features in the genomes of mucin using bacteria. Recently, the genome sequence of 
Bifidobacterium bifidum PRL2010 was fully decoded (Turroni, Bottacini et al. 2010) revealing 
novel insights into the metabolic strategies followed by this strain to metabolize mucin -derived 
carbohydrates. In silico analyses of its chromosome together with functional genome approaches 
revealed the existence of a gene set involved in mucin metabolism.  
The main monosaccharide constituents of mucin-derived glycoproteins are N-acetylglucosamine, 
N-acetylgalactosamine, fucose, and galactose, and these glycoproteins are sometimes decorated 
with sialic acid and sulfate groups (Forstner 1995). These investigations suggested the existence 
of specific B. bifidum PRL2010 enzymat ic pathways for example by the activity of enzymes that 
remove sialic acid and fucose moieties from galactoN-b iose (GNB) and its extended derivatives 
present in various mucin O-glycans (Podolsky 1985, Lloyd, Burchell et al. 1996, Wada, Ando et 
al. 2009). Another example of host-glycans is represented by HMOs (Sela, Chapman et al. 2008). 
HMOs are present at 10 to 20 g/liter in human milk (Kunz, Rudloff et al. 2000, Urashima, Saito 
et al. 2001) and are characterized by their complex structures  (Kobata and Ginsburg 1972, 
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Haeuw-Fievre, Wieruszeski et al. 1993). More than 130 types of HMOs have been isolated and 
lacto-N-tetraose (Gal1,3GlcNAc1,3Gal1,4Glc), lacto  N-fucopentaose 
 (Fuc1,2Gal1,3GlcNAc1,3Gal1,4Glc), lacto-N-difucohexaose (Fuc1,2Gal1,3 [Fuc1,4] GlcNAc1, 
3Gal1,4Glc) and 2-fucosyllactose (Fuc1,2Gal1,4Glc) are known to be abundant , especially in  
colostrums (Erney, Malone et al. 2000, Urashima, Saito et al. 2001, Asakuma, Urashima et al. 
2008). LoCascio et al. and Ward et al. (Ward, Ninonuevo et al. 2006, LoCascio, Ninonuevo et al. 
2007) demonstrated the ability of biﬁdobacteria to assimilate HMOs as the sole carbon source by 
conducting growth experiments and mass spectrometric analyses  (Wada, Ando et al. 2008). 
Notably, Bifidobacterium longum subsp. infantis ATCC15697, which was isolated from infant 
feces, was demonstrated to possess a 43 kb gene cluster responsible for transport and utilizat ion 
of HMOs (Sela, Chapman et al. 2008). Notably the proteome of this strain encompasses  four 
glycosyl hydrolases that were predicted to cleave HMOs such as sialidase, a fucosidase, an N-
acetyl-hexosamin idase and a galactosidase (Sela, Chapman et al. 2008).  
In contrast, the genomes of B. animalis subsp. lactis strains and B. breve UCC2003, do not 
encompass the genetic loci p redicted to be involved in the synthesis of the enzymatic arsenal 
needed for HMO degradation. However, they are predicted to encode the enzymes necessary for 
the breakdown of complex plant-derived oligosaccharides, which is a clear indication of plant-
niche-speciﬁc adaptation (Ryan, Fitzgerald et al. 2005, Barrangou, Briczinski et al. 2009, 
Pokusaeva, O'Connell-Motherway et al. 2009, Pokusaeva, Fitzgerald et al. 2011).  
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1.7 Microbial molecules mediating host interaction 
The adhesion of pathogenic and commensal bacteria to the host cells and tissues is considered as 
an important step in the initiation of disease or mediating beneficial effects to the host, 
respectively (Scott and Zahner 2006, Linke-Winnebeck, Paterson et al. 2013). The adhesion to 
GIT mucosa is considered as an essential colonization step for gut commensals as well as by 
pathogenic bacteria (Scott and Zahner 2006). Human gut commensals and pathogenic bacteria 
may share few common mechanis ms of adhesion to epithelial tissues, and thus commensal 
bacteria may compete with pathogens by occupying adhesion sites  (Lebeer, Vanderleyden et al. 
2010, Ashida, Ogawa et al. 2012). Furthermore, adhering commensals have close contact with 
the host epithelium and are proposed to prime the immune system and to affect gut maturation as 
well as to enhance the epithelial integrity (Ewaschuk, Diaz et al. 2008, Lebeer, Vanderleyden et 
al. 2010, Maynard, Elson et al. 2012, Kainulainen, Reunanen et al. 2013). So far, little is known 
about the genetic basis of interactions  between gut commensals such as bifidobacteria and the 
intestinal host mucosa. Valuable candidates modulating the microbe-host interaction are 
including capsular polysaccharides (EPS), serpin, teichoic acids, pili sortase-dependent and Type 
IVb pili (for details see below). 
1.7.1 Capsular polysaccharides 
Human gut commensals are known to synthesize cell envelope-associated structures, which are 
claimed to sustain a pivotal role in  sustaining microbe-host interactions. Many sequenced 
genomes of bifidobacteria are pred icted to encode an extracellular polysaccharide (EPS) and such 
an extracellu lar structure may be important in bacterial colonizat ion or adherence to host cells, 
while it could also contribute to resistance to stomach acids and bile salts (Perez, Minnaard et al. 
1998, Ventura, Canchaya et al. 2007). Exopolysaccharides (EPS) are carbohydrate polymers 
present as an extra-cellu lar layer covering the surface of Gram-positive as well as Gram-negative 
bacteria. It seems that these polymers could play a relevant role in the cross -talk between the 
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EPS-producing bacteria and the gut environment of the host (Hidalgo-Cantabrana, Sanchez et al. 
2014). 
1.7.2 Serine protease inhibitors 
Serine protease inhibitor, also known as serpin, represents a large class of polypeptide serine 
protease inhibitors that are involved in regulation of a wide spectrum of protease -mediated 
processes (Silverman, Bird et al. 2001, Gettins 2002). Biﬁdobacteria such as B. breve UCC2003 
as well as Bifidobacterium breve 210B (Alvarez-Mart in, Motherway et al. 2012) are pred icted to 
produce serpins, which are aimed to protect their surface-exposed and extracellular proteins  
(Turroni, Foroni et al. 2010). Their production is enhanced when bacterial cultures are exposed to 
various host-derived proteases (Turroni, Foroni et al. 2010, Alvarez-Mart in, O'Connell 
Motherway et al. 2012). This ﬁnding is highly relevant since many of these proteases are 
normally found in the human gut and thus the presence of a protease inhibitor may provide an 
ecological advantage to biﬁdobacteria since serpin activity may protect them against  these host 
proteases.  
1.7.3 Teichoic acids 
Gram-positive bacteria have been shown to modify their cell envelopes in mult iple ways to 
prevent the access and damage by antimicrobial molecu les  (Xia, Kohler et al. 2010). In addition 
to covalent modiﬁcation of peptidoglycan (PG) and phospholipids, the  production of protective 
capsule and slime polymers, and the secretion of proteinaceous evasins (Foster 2005, Kraus and 
Peschel 2008), most Gram-positive bacteria have teichoic acids  (TAs) or related glycopolymers 
that play crucial roles in bacterial survival under disadvantageous conditions and during gut 
colonizat ion and infection (Weidenmaier, Kokai-Kun et al. 2004, Weidenmaier, Kokai-Kun et al. 
2004, Dubail, Bigot et al. 2006, Weidenmaier and Peschel 2008, D'Elia, Henderson et al. 2009, 
Kohler, Weidenmaier et al. 2009). The known TA functions are: i) protection against harmful 
molecules and environmental stresses, ii) control of enzyme activ ities and cation concentrations 
in the cell envelope, and iii) binding to receptors and surfaces  (Xia, Kohler et al. 2010) TAs are 
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usually constitutively produced and either connected to PG (wall teichoic acids, WTA) or to the 
cytoplasmic membrane (lipoteichoic acids, LTA). LTA polymers are attached to the cytoplasmic 
membrane via a glycolip id anchor, which is a diglucosyl diacylglycerol in Sthaphylococus 
aureus and most other staphylococcal species (Wicken and Knox 1975). As a likely consequence 
of the unique biosynthetic pathway, the structures of LTA are usually less diverse than those of 
WTA (Fischer 1994). At the 2-hydroxyl group of the glycerol, S. aureus LTA is substituted with 
D-alany ester or a-GlcNAc (Fischer 1994). Very litt le is known about the molecular structure of 
the components of the cell wall of bifidobacteria. Bifidobacterium bifidum subspecies 
pennsylvanicum was the first example among Gram-positive bacteria with an unusual 
lipoteichoic acid, it contains L-alan ine in place of the D-alanine found in lipoteichoic acids  
(Fischer 1987). In a recent work it was suggested the therapeutic efficacy of lipoteichoic 
acid of Bifidobacterium because it could enhance antitumor effect (Xie, Wang et al. 2012). 
1.7.4 Pili 
 Pili (Latin for “hairs”) or ﬁmbriae (Latin for “threads”) are  long proteinaceous structures, ﬁrst 
observed in Gram-negative bacteria in the early 1950s, by electron microscopy  
(Houwink and van 1950). These polymers are composed of non-covalently associated protein 
subunits called pilins or ﬁmbrins. In Gram-negative bacteria, four types of pili have been 
characterized in detail over the last decades: the type I and type P of Escherichia coli 
(chaperone/usher pathway); the type III of Yersinia, Shigella and Salmonella  (secretion needle); 
the type IV of Neisseria; and curli of E. coli and Salmonella. (Danne and Dramsi 2012). These 
various pili have been implicated in many functions such as adhesion to host cells, bioﬁlm 
formation, DNA uptake, immune evasion, etc. (Fronzes, Remaut et al. 2008). In Gram-positive 
bacteria, pili were ﬁrst observed in  Corynebacterium renale in 1968 (Yanagawa, Otsuki et al. 
1968, Yanagawa and Otsuki 1970). Th is remarkable observation remained forgotten for years 
until the ﬁrst molecular characterization of pilus biogenesis in Corynebacterium diphtheria by 
Ton-That and Schneewind (Ton-That and Schneewind 2003, Ton-That, Marraffin i et al. 2004). 
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Pili were subsequently found in the three major streptococcal pathogens  (Streptococcus 
agalactiae, Streptococcus pyogenes, and Streptococcus pneumoniae) and later on in many other 
Gram-positive bacteria (Telford, Barocchi et al. 2006, Mandlik, Swierczynski et al. 2008, 
Hendrickx, Budzik et al. 2011, Kreikemeyer, Gamez et al. 2011, Kang and Baker 2012). These 
pili are very d ifferent from those described in Gram-negative species. They are made of 
covalently linked pilins, forming a thin string of beads of approx. 3 nm of diameter and of 
various lengths (0.1- 5 µm). Pili are encoded within pathogenicity islands known as pilus islands, 
which have greatly facilitated their discovery in the availab le genome sequences. In Gram-
positive bacteria, surface proteins are anchored to the cell wall by sortases. These enzymes 
covalently link proteins  via a transpeptidation mechanism, to assemble pili. In Actinomyces the 
fimQP and the fimAB-loci encode fimbrial structures composed of a shaft protein, being either 
FimA or FimP, and a tip protein, represented by either FimB or FimQ, respectively (Yeung and 
Ragsdale 1997). Fimbriae have never been described in bifidobacteria, but these appendages 
could mediate microbial adhesion and colonization of epithelial, mucosal, or other host cell 
surfaces (Schell, Karmirantzou et al. 2002). The genome sequence of B. longum NCC2705 has 
revealed the presence of a gene with the 30% of identity to fimbriae structures of Actinomyces 
naeslundii, but it remains to be determined if they act like fimbriae, and if they possibly 
contribute to attachment or retention in the GIT (Schell, Karmirantzou et al. 2002). 
1.7.5 Type IVb pili 
Recently, the Gram-positive pathogen Mycobacterium tuberculosis was found to express type 
IVb pili, which are encoded by the tad locus, similar to those speciﬁed by the Gram-negative 
tight adherence (tad) locus (Danelishvili, Yamazaki et al. 2010). Homologs of tad genes have 
been identiﬁed in the genomes of Corynebacterium diphtheria, Thermobiﬁda fusca, and 
Streptomyces coelicolor (Tomich, Planet et al. 2007, Pelicic 2008). The Tad pili biosynthesis 
apparatus was ﬁrst described in Actinobacillus actinomycetemcomitans and allows the production 
and assembly of pili, which in this bacterium mediate adhesion to surfaces and  are essential for 
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colonizat ion and pathogenesis (Kachlany, Levery et al. 2001, Schreiner, Sinatra et al. 2003). The 
Tad pilus is comprised of homopolymers of a single pilin subunit, although some pili possess an 
adhesive subunit at the pilus tip or can be decorated with pseudopilins  along the pilus (Tomich, 
Planet et al. 2007, Pelic ic 2008). In addition, clear homologs of the tad locus and the associated 
tadV gene encoding the prepilin peptidase are present in several B. breve strains examined by 
CGH (Comparat ive Genome Hybrid ization) as well as in all completed biﬁdobacterial genome 
sequences (Motherway, Zomer et al. 2011). Intriguingly, in B. breve UCC2003 a locus dedicated 
to the production of type IVB or Tad pili was among the most highly up-regulated genes during 
in vivo trials involv ing mouse models. Mutational analysis demonstrated that the UCC2003 tad 
gene cluster is crucial for efficient in vivo gut colonization in murine models, (Motherway, 
Zomer et al. 2011).  
 
Fig 1.7: Schematic overview of the Gram-positive cell wall with main macromolecular structures implicated in host–
microbe interaction. Wall and lipoteichoic acids (WTA and LTA), exopolysaccharide (EPS), as well as secreted proteins 
(SP), membrane proteins (MP), cell wall-associated proteins (CWP), lipoproteins (LPP), membrane-associated proteins 
(MAP), surface layer proteins (SLP), fimbrial proteins (Fim), tad proteins (TAD) and the sortase-dependent assembly 
apparatus (SRT) are indicated [This image has been taken by (Turroni, Ventura et al. 2014)]. 
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1.8 Roles of pili in Gram-positive bacteria  
To colonize host tissues, bacteria use a variety of surface exposed proteins, such as  adhesins and 
proteases, as well as capsule and proteins interfering with innate immune clearance mechanisms. 
Several of these pilus-associated adhesin subunits are described as MSCRAMMs (microbial 
components recognizing adhesive matrix molecules), which mediate binding to host extracellu lar 
matrix (ECM) and are crucial for colonization and invasion . Pili contribute to init ial steps of 
infection i.e . bacterial adhesion and colonization of host tissues (Kang and Baker 2012). They 
also play important roles in bioﬁlm formation. Indeed, the SpaCBA pilus of Lactobacillus 
rhamnosus GG is involved in binding to human mucus via the adhesin SpaC. The presence of 
SpaC likely exp lains the ability of L. rhamnosus to persist longer in the human intestinal tract 
than strain LC705, which does not express pili during an intervention trial (Kankainen, Paulin et 
al. 2009, Lebeer, Vanderleyden et al. 2010). More recently, the SpaCBA pilus was  shown critical 
for efﬁcient adherence to the human intestinal epithelial cell line Caco-2 as well as for bioﬁlm 
formation (Lebeer, Claes et al. 2012). As reported earlier for opportunistic bacteria, these data 
support the importance of pilus in host-colonization and persistence for commensal bacteria of 
the microbiota. 
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1.9 The impact of bifidobacteria on the resident members of the gut 
microbiota 
To determine the molecu lar mechanis ms driving the microbe-microbe as well as microbe-host 
interaction, Sonnenburg et al (Sonnenburg, Chen et al. 2006) have colonized germ-free mice with 
Bacteroides thetaiotaomicron, a prominent component of the adult human gut microbiota, and 
Bifidobacterium longum NCC2705, another common human gut commensal. Both bacterial 
genomes have been sequenced, so it has been possible to use a B. thetaiotaomicron/B. longum 
‘‘community’’ GeneChip to simultaneously  examine how each organism affects the other’s 
transcriptome in a specified intestinal habitat of the host. This study highlighted how two resident 
human gut commensals influence the capacity of carbohydrate harvesting. In fact, whole genome 
transcriptional profiling of both bacterial species in their gut habitat revealed that the presence of 
B. longum subsp. longum NCC2705 elicits an expansion in the diversity of polysaccharides 
targeted for degradation by B. thetaiotaomicron (e.g., mannose- and xylose-containing glycans), 
and induces host genes involved in innate immunity. In fact, the presence of B. longum subsp. 
longum NCC2705 produced statistically signiﬁcant changes in expression of 31 B. 
thetaiotaomicron glycoside hydrolases and two polysaccharide lyases when compared to B. 
thetaiotaomicron residing in the ceca of mono-associated mice (the vast majority of these genes 
(29/33) were up-regulated). Alternatively, co-colonization could result in changes  in the 
environment, such as pH or osmolarity that render mannosidases expressed by NCC2705 more 
stable, or more efﬁcient, resulting in their subsequent down -regulation. Each bacterial species, 
when present alone in the cecum, possesses a complement of glycoside hydrolases that is 
insufﬁcient for efﬁcient degradation of available xy lose-containing glycans. However, when their 
repertoires of glycoside hydrolases are combined, complementary enzymes activities allow the 
two bacterial species to participate in a ‘‘synergistic’’ harvest of this class of glycans in a similar 
fashion to what previously described for other mixed microbial communities that degrade 
cellu lose. This gnotobiotic mouse model provides a controlled case study of how a resident 
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symbiont and a probiotic species adapt their substrate utilization in response to one another, and 
illustrates both the generality and specificity of the relat ionship between a host, a component of 
its microbiota, and intentionally consumed microbial species. The ability of B. longum to repress 
host expression of antibacterial proteins may not only promote its own survival in the gut, but 
also inﬂuence the composition, structure, and function of its  microbial community  
. 
2. Aim of the Research 
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The human gastrointestinal (GIT) microbiota is a complex microbial environmental whose 
functions are believed to have a significant impact on human physiology. The Bifidobacterium 
genus is one of the most dominant members of the GIT of infants and bifidobacteria are 
frequently explo ited as healthy components or probiotic ingredient in many functional foods. 
Despite the importance of bifidobacteria as inhabitants of human microbiota, only recently the 
probiogenomics studies (based on genetics, physiology and functional genomics) have 
highlighted the importance of these bacteria to adapt and interact with the host and with the other 
microorganis ms of the GIT. The interaction between bacteria and the human affects the host in 
different ways. The aim of this PhD thesis is to investigate the molecular basis sustaining the 
interaction of the human commensal microorganis m Bifidobacterium bifidum PRL2010 with the 
human host as well as with other human gut commensals.  
Chapter 3 describes the analysis of mupirocin resistance in the majority of biﬁdobacterial species 
to obtain a valid method to screen and isolate the bibifidobacteria. Furthermore, it was proposed 
a structural mechanis m to exp lain mupirocin resistance in biﬁdobacteria.  
Chapter 4 shows a physiological characterization of B. bifidum PRL2010. In particular some 
abilities of this commensal bacterium, i.e to resist to the harsh environmental conditions of the 
human gut, to adhere to intestinal cells and to prevent/reduce activity of pathogenic bacteria, are 
reported. 
Chapter 5 proposes a novel method to transform and to genetically manipulate B. bifidum 
PRL2010.  
In Chapter 6, provides molecular data about putative candidate bifidobacterial proteins, i.e. 
sortase-dependent pili, involved in the interaction with host.  
Chapter 7 and Chapter 8 are focusing on the molecular characterization of sortase-dependent pili 
encoded by B. bifidum PRL2010. It was evaluated the effect of treatments simulat ing the passage 
of bifidobacterial cells through the GIT on the regulation of the expression of sortase-dependent 
pili. Furthermore, it was assessed how the interaction with the other gut commensals might affect 
the production of these extracellular proteins . 
 28 
 
Finally, in Chapter 9 it is evaluated the ability of B. bifidum PRL2010 to survive into a food 
complex matrix such as kefir milk. Moreover, it was investigated through transcriptional 
analysis, the expression of sortase-dependent pili in this complex symbiotic ecosystem. 
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3. Insights into physiological and genetic mupirocin susceptibility 
in bifidobacteria 
Serafini F., Bottacini F., Viappiani A., Baruffini E., Turroni F., Foroni E., Lodi 
T., van Sinderen D., Ventura M. 
 
 
 
 
 
 
 
 
 
 
This chapter was published in: 
Appl. Environ. Microbiol. (2011) 77(9): 3141-6. 
Reprinted with permission from American Society for Microbiology  
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4. Evaluation of adhesion properties and antibacterial activities  
of the infant gut commensal Bifidobacterium bifidum PRL2010 
 
Serafini F., Strati F., Ruas-Madiedo P., Turroni F., Foroni E., Duranti S., Milano 
F., Perotti A., Viappiani A., Guglielmetti S., Buschini A., Margolles A., van 
Sinderen D., Ventura M. 
 
 
 
 
 
 
 
 
 
 
This chapter was published in: 
Anaerobe (2013) 21: 9-17 
Reprinted with the permission from Elsevier  
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5. An efficient and reproducible method for transformation of 
genetically recalcitrant bifidobacteria 
 
Serafini F., Turroni F., Guglielmetti S., Gioiosa L., Foroni E., Sanghez V., 
Bartolomucci A., O’Connel Motherway M., Palanza P., van Sinderen D., 
Ventura M. 
 
 
 
 
 
 
 
 
 
 
This chapter was published in: 
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Reprinted with the permission from John Wiley and Sons publisher  
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Abstract 
Cell surface pili have recently been found in many different bifidobacterial species, including the 
infant gut commensal Bifidobacterium bifidum PRL2010. Pili produced by PRL2010 have been 
shown to be important molecu lar mediators for bacterial interaction with its human host. 
However, nothing is known about the modulation of their expression in response to cues that 
reflect the gastro intestinal environment, such as thermal, acid ic and osmotic challenges, or the 
presence of other gut micro -organisms. Here, we have investigated how different stress 
conditions that simulate the gastro-intestinal niche influence the expression of PRL2010 sortase-
dependent pili, and how this may impact on the coexistence and interaction with other human gut 
commensals.  
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INTRODUCTION 
Bifidobacteria are common gut inhabitants of mammals, in particular during the first phase of life 
when they represent one of the most dominant me mbers of the intestinal microbiota (Turroni, 
Peano et al. 2012, Ventura, Turroni et al. 2012). Bifidobacteria are ab le to establish themselves in 
such ecosystem thanks to different genetic strategies involving metabolic adaptation to natural 
substrates present in the gut such as undigested diet-derived poly/oligo-saccharides, and/or host-
derived glycans [for a review see (Pokusaeva, Fitzgerald et al. 2011)]. Pilus-like structures have 
recently been described to be encoded by various bifidobacterial species (Foroni, Serafini et al. 
2011, Motherway, Zomer et al. 2011, Turroni, Serafini et al. 2013), and reported to be pivotal for 
bifidobacterial gut colonization as well as for human host interactions. In this context, 
Bifidobacterium bifidum PRL2010, a strain isolated from infant stool, revealed the abundant 
presence of appendages known as sortase-dependent pili, which decorate the bacterial cell 
surface (Turroni, Bottacini et al. 2010, Turroni, Serafin i et al. 2013). These sortase-dependent pili 
are highly expressed during in vivo colonization of mice as well as upon contact with a 
monolayer of human cells (Turroni, Serafini et al. 2013). Notably, heterologous expression of the 
coding sequences of these B. bifidum PRL2010 appendages in non-piliated Lactococcus lactis 
enhanced adherence to human enterocytes , promoted interaction with extracellu lar matrix 
proteins and stimulated bacterial aggregation. Furthermore, in vivo murine challenges with such 
piliated L. lactis cells evoked a higher TNFα response, supporting the notion that PRL2010 
sortase-dependent pili not only contribute to adherence but also display immunomodulatory 
activity (Turron i, Serafini et al. 2013). 
In B. bifidum PRL2010 as well as in other bifidobacteria, the genes for pilus format ion and 
assembly are arranged in one or more loci, each of which encode one major pilin (represented by 
a FimA or FimP homolog), one minor p ilins (represented by a FimB or FimQ homolog), and a 
pilus-specific sortase (Foroni, Serafini et al. 2011, Turroni, Serafini et al. 2013), in a similar 
fashion as described for Actinomyces naeslundii (Ton-That and Schneewind 2003, Mishra, Wu et 
al. 2010). In Actinomyces the fimQP and the fimAB-loci encode fimbrial structures composed of 
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a shaft protein, being either multimers of FimA or FimP, and a tip protein, represented by either 
FimB or FimQ, respectively (Yeung and Ragsdale 1997). Transcriptomics experiments have 
highlighted how the subunits that form the sortase-dependent pili of B. bifidum PRL2010 are 
differently expressed upon cultivation on different carbon sources, including diet -based 
carbohydrates or host-produced glycans (Foroni, Serafini et al. 2011). However, nothing is 
known about how pilus production may be influenced by environmental factors, such as those 
encountered by enteric bacteria during the approaching steps ahead of their establishment in their 
natural ecological n iche or upon colonizat ion of the human gut. Furthermore, biofilm format ion 
involving microbe-microbe interaction has been shown to be largely influenced by pili synthesis 
in oral pathogens like Actinomyces and oral streptococci, i.e., Streptococcus gordonii, 
Streptococcus sanguinis, Streptococcus mitis and Streptococcus oralis (Okahashi, Nakata et al. 
2011). In the human gut a large p lethora of bacteria are believed to co-exist and may interact with 
each other (Sonnenburg, Chen et al. 2006), which may u ltimately affect the expression of host-
responsive molecules like pili. Here, we evaluate the expression of sortase-dependent pili of B. 
bifidum PRL2010 in response to environmental cues that are reflective of the gastro intestinal 
environment, and to the co-cultivation with various gut micro-organis ms.  
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Materials and Methods  
Bacterial strains and growth conditions . Bifidobacterial strains used in this study are listed in 
Table 1, and were cultivated in an anaerobic atmosphere (2.99 % H2, 17.01 % CO2 and 80 % N2) 
in a chamber (Concept 400, Ruskin) on De Man-Rogosa-Sharp (MRS) (Scharlau Chemie, 
Barcelona, Spain) supplemented with 0.05 % (w/v) L-cysteine hydrochloride (MRSc) and 
incubated at 37°C for 16 h. Lactobacillus paracasei LMG9192 was cultivated in MRSc at 37°C 
under aerobic conditions. Saccharomyces cerevisiae BY4741 was cultivated in Yeast Extract  
Peptone Dextrose (YPD) (Oxoid) medium at 30°C under aerobic condit ions. 
Response to different physiological conditions. Following 24 h of growth at 37°C under 
anaerobic conditions, bifidobacteria were harvested by centrifugation, washed twice in saline 
solution (0.09 % NaCl, wt/vol), and brought to an inoculum of 10
8
 to 10
9
 CFU/ml. In order to 
simulate passage through the gastrointestinal tract, an inoculum of 10
7
 CFU of bacteria was 
added to 10 ml of 2, 6 or 10 % of a saline solution (9 g/L NaCl), pH 3 solution, after which the 
resulting suspension was incubated at 37°C under anaerobic conditions for 16 hours as 
previously described (Sincock and Robinson 2001). The same procedure was used to inoculate B. 
bifidum PRL2010 in oxgal (Sigma-Aldrich) 0.5 % or at pH 4. In the case of pancreatin exposure, 
the cell suspension was neutralized by washing with phosphate buffer at pH 7.0, and cells were 
then resuspended in pancreatin solution and incubated at 37°C under anaerobic conditions for 4 
h. Pancreatic solution was prepared immediately before use as follows: pancreatin from porcine 
pancreas (1% wt/vol; Sigma-Aldrich) was resuspended in sterile saline solution (0.5 %, wt/vol), 
and the pH was adjusted to 8.0 as described previously (Chenoll, Casinos et al. 2011). Moreover, 
the response of bifidobacteria to thermal fluctuations (25 and 30°C) was tested according to the 
protocol previously described (Ventura, Canchaya et al. 2004), while acidic stress was examined 
as previously described (Ventura, Canchaya et al. 2004). Samples were taken after four or sixteen  
hours, after which RNA extract ions were performed. Assays were performed in triplicate and 
data were obtained from independent experiments. 
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Co-cultivation assays. Approximately 10
8
 cells/ml of each of the following strains: B. bifidum 
PRL2010, B. breve 12L, B. adolescentis 22L, B. animalis subsp. lactis Bl12, L. paracasei 
LMG9192, S. cerevisiae BY4741 or these strains in co-cultivation with B. bifidum PRL2010 was 
inoculated in 6 ml of MRSc. Cell suspensions were mixed and incubated overnight at 37°C in  
anaerobic conditions in order to allow growth of PRL2010 cells. The suspensions were harvested 
and RNA extraction was performed to analyze the expression of pili through real time analyses  
(see below). 
Evaluation of the cell density of PRL2010 in co-cultivation trials. Possible enhancement 
and/or reduction of PRL2010 growth as a consequence of the co-cultivation with other bacteria 
was monitored by quantitative real-time reverse transcription PCR (qRT-PCR). The copy-
number of a gene for a given strain used in the co-cultivation experiments was evaluated and 
normalized according to the genome size and compared to the growth rate of each individually  
cultivated micro-organis m. In the case of PRL2010 we used the following primer couple: 
BBPR_0282-UNI (5’-GCGAACAATGATGGCACCTA-3’) and BBPR_282-REV (5’-
GTCGAACACCACGACGATGT-3’). In the case of B. breve 12L, we used 12L-UNI (5’-
CGAAGTTCCAGTTAACCAT-3’) and 12L-REV (5’-GTTCTTCGCGTTCCAGATGT-3’); for 
B. adolescentis 22L, we employed the PCR primers 22L-UNI (5’-
GACCAAGCCAACCAGTTCAT-3’) and 22L-REV (5’-TTGGTGGCCTTGTAGTAGCC-3’);  
for B. animalis subsp. lactis Bl12, the following PCR primers l12-UNI 
(5’CGGTCATCCAGGTCGATA-3’) and l12-REV (5’-CAGGGTATATGTGCGGTCAG-3’);  
for S. cerevisiae BY4741, the fo llowing PCR primer pair BY4741-UNI (5’-
GGACTCTGGACATGCAA-3’) and BY4741-REV (5’-ATACCCTTCTTAACACCT-3’); for L. 
paracasei LMG9192, primers 9192-UNI (5’-AGCAGTAGGGAATCTTC-3’) and 9192-REV 
(5’-CATGGAGTTCCACTGTC-3’). 
Auto-aggregation and co-aggregation assays . These experiments were performed using 
PRL2010 cells placed in contact with cells from another micro -organis m (Table 1). Auto-
aggregation assays were carried out according to Del Re et al. (Del Re, Sgorbati et al. 2000) with 
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subsequently described modificat ions (Kos, Suskovic et al. 2003). Briefly, bacteria were grown 
for 16 h at 37°C in MRSc under anaerobic conditions. Cells were harvested by centrifugation at 
5000 g for 15 min , washed twice and resuspended in phosphate buffered saline (PBS). 
Approximately 10
8 
cells/ml of each strain or both strains was inoculated in 10 ml PBS, then cell 
suspensions were mixed and the auto-aggregation and co-aggregation was determined during five 
hours of incubation at 37°C under anaerobic conditions. Every hour the absorbance (A) of 0.5 ml 
of the upper suspension was measured at 600nm. The auto-aggregation percentage is expressed 
as: 
 1- (At/A0) x 100, where A t is  the absorbance at time t=1, 2, 3, 4 or 5 h and A0 the absorbance at 
t=0. 
The percentage of co-aggregation was calculated using the following equation (Handley, Harty et  
al. 1987): 
                
         
     
where x and y represent each of the two strains in the control tubes, and (x + y) the mixture. 
Results are expressed as the percentage reduction in the absorbance of a mixed suspension 
compared with the single bacterial suspension. 
Flow Cytometry assay. In flow cytometry (FCM) particles/cells passing through the beam will 
scatter light, which is detected as forward scatter (FSC) and side scatter (SSC). FSC correlates 
with the cell size, shape and cell aggregates , whereas SSC depends on the density of the 
particle/cell (i.e. number of cytoplasmic granules, membrane size), and in this manner cell 
populations can often be distinguished based on differences in their size and density 
(Gunasekera, Veal et al. 2003, Cronin and Wilkinson 2010). The combination of scattered and 
fluorescent light is measured by a number of detectors as they pass an interrogation point in a 
flu id stream (Sincock and Robinson 2001). The effect of culture association between piliated 
PRL2010 cells and other microorganisms (Bifidobacterium sp., L. paracasei, and S. cerevisiae) 
on the dimension of cell aggregates of B. bifidum PRL2010 have been investigated by FCM 
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evaluating the FSC parameter. Cell suspensions prepared, as described before, were analyzed 
using the flow cytometer Accuri C6 (BD Biosciences, Milan, Italy) using the following threshold 
settings: FSC 5000 and SSC 4000, 20,000 total events collected. All parameters were co llected as 
logarithmic signals. The 488 nm laser was used to measure the FSC values. The rate of events in 
the flow was generally lower than 2500 events s
-1
. The data obtained were analyzed using the BD 
Accuri
TM
 C6 software version 1.0 (BD Biosciences, Milan, Italy). Previous experiments were 
carried out using the same instrument settings but labeling the cell suspension with SYBR green I 
(SIGMA Aldrich, Milan, Italy) and evaluating the relat ive green fluorescence intensity 
(excitation 488 nm, emission filter 530/30) in order to estimate the amount of particles 
background in the cell suspension. Simultaneous with the FCM analysis the cell suspension was 
observed using a phase contrast microscope Axio Scope A.1 (Zeiss, Milan, Italy), and images 
were acquired using a TiEsseLab DV5000 camera (TiEsseLab srl, Milan, Italy) a Bel Eurisko v. 
2.9 (BEL Engineering srl – Monza, italy). 
RNA isolation. Total RNA was isolated using a previously described method (Turroni, Foroni et 
al. 2011). Briefly, cell pellets/tissue materials were resuspended in 1 ml of QUIAZOL (Qiagen, 
UK) and placed in a tube containing 0.8 g of glass beads (diameter, 106 μm; Sigma). Cells were 
lysed by shaking the mix on a BioSpec homogenizer at  4°C for 2 min (maximum setting). The 
mixture was then centrifuged at 12,000 rpm for 15 min, and the upper phase containing the RNA -
containing sample was recovered. The RNA sample was further purified by phenol extract ion 
and ethanol precipitation accord ing to an established method. The quality of the RNA was 
checked by analysing the integrity of rRNA molecu les by Experion (BioRad).  
qRT-PCR. cDNA was synthesized and purified using the iScript cDNA synthesis kit (Bio -Rad, 
Hercules, CA), according to the supplier’s instructions. qRT-PCR was performed using the 
CFX96 system (BioRad, CA, USA), fo ld change was evaluated through the estimation of the CT 
values with the aid of the CFX96 software (BioRad, CA, USA). Each PCR reaction mix 
contained the following : 12.5μl 2x SYBR SuperMix Green (BioRad, CA, USA), 1 μl of cDNA 
dilution, each of the forward and reverse primers at 0.5 μM and nuclease-free water was added to 
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obtain a final volume of 20 μl. PCR products were detected with SYBR Green fluorescent dye 
and amplified according to the following protocol: one cycle of 95°C for 3 minutes, followed by 
39 cycles of 95°C for 5 s and 60°C for 20 s. Melting curve: 65°C to 95°C with increments of 
0.5°C/s. In each run, negative controls (no cDNA) for each primer set were included. The 
primers involved in qRT-PCR experiments were previously described (Foroni, Serafin i et al. 
2011, Turroni, Serafin i et al. 2013). Fo ld change was calculated using the CFX96 software 
(BioRad). The expression was considered significant when the fold-induction was more than two. 
Western Blotting. Overnight cultures were harvested by centrifugation and resuspended in lysis 
buffer (100 mM NaH2PO4, 10 mM Tris-HCl, 8 M urea pH 8). This bacterial cell suspension was 
then subjected to sonication using six 10 s bursts at 200–300 W with a 10 s cooling period 
between each burst. Bacterial cell envelopes were collected by centrifugation at 6,000 rpm for 2 
minutes, the pellets were resuspended in 60 μl of PBS-lysis buffer containing SDS and β-
mercaptoethanol, and boiled at 100°C for 15 min. Proteins were separated on a 10 % SDS-
polyacrylamide gel and then transferred onto a nitrocellulose membrane, which was blocked 
overnight at 4 C in Tris Buffered Saline (TBS) supplemented with 0.05 % Tween 20 (TBST) 
containing 5 % skim milk powder (blocking solution). Membranes were washed three times with 
TBST for 5 min and then incubated with the polyclonal antibody Abpil3 (diluted 1:5000 in TBST) 
for two hours at RT. Immunoblots were then washed three times for 10 min with TBST followed  
by immunodetection with IR Dye 680 Goat anti-rabbit for one hour. The nitrocellulose 
membrane (BioRad) was scanned using the Odyssey Infrared Imager at an intensity of 3.  
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RES ULTS AND DISCUSS ION 
Response to di fferent physiological conditions. Expression of pilus-encoding genes from 
various pathogenic bacteria, such as Streptococcus pyogenes and Enterococcus faecium, have 
previously been shown to be affected by various environmental factors, e.g. temperature and 
acidity, encountered by such microorganisms during their transit through or residence in various 
compartments of the human body (Hendrickx, Bonten et al. 2008, Nakata, Koeller et al. 2009, 
Jiang, Park et al. 2012). Thus, we decided to investigate if environmental stresses including 
exposure to thermal, osmotic and acid ity fluctuations, which resemble those encountered by a 
microbial cell when it approaches and passes through the gastrointestinal (GIT) tract, might 
influence the production of sortase-dependent pili using our model gut microorganism of B. 
bifidum PRL2010. Furthermore, it has previously been suggested that environmental stresses 
may stimulate pre-adaption of enteric bacteria to the gut environment through for example the 
production of capsular structures (Hidalgo-Cantabrana, Sanchez et al. 2013), and it may therefore 
be that the synthesis of other microbe-host interaction effector molecules such as pili are also 
influenced [for rev iew see (Ventura, Turroni et al. 2012)].  
Common stresses to which enteric bacteria may be exposed are represented by osmotic insults 
derived from osmotic fluctuations of the diet as well as from temperature challenges [for a review 
see (Ventura, Canchaya et al. 2006)]. In order to determine if transcription of the major p ilin  
subunit-encoding genes (BBPR_1707 fimA and BBPR_0283 fimP genes), the minor pilin  
subunit-encoding genes (BBPR_1708 fimB and BBPR_0282 fimQ genes) or the sortase-encoding 
genes (BBPR_1709 and BBPR_284) of the B. bifidum PRL2010 pil2 and pil3 loci, respectively, 
is altered following temperature fluctuations or osmotic shock, a qRT-PCR procedure was 
employed. The reference condition used were mRNA samples isolated from PRL2010 cultures 
cultivated in MRS broth at 37°C without lysine, which is a condition that do not allow the 
production of pili sortase-dependent by PRL2010 cells (Turroni, Serafini et al. 2013). The 
mRNA samples used in these experiments were isolated from B. bi fidum PRL2010 cultures 
grown at temperatures ranging from 25°C to 37°C (Fig. 1), which might simulate thermal 
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conditions encountered by bacterial cells prio r the approaching to  the intestine (e.g., diet as well 
as in the upper GIT compartments), or in medium with a NaCl concentrations ranging of 2 % to 
10 % (Fig. 1). Based on the qRT-PCR results, the highest transcription level of the pil3 locus was 
shown to occur following cultivation of PRL2010 cells at 30°C or incubation in a medium 
containing 2 % NaCl (Fig. 1). The transcriptional levels obtained under NaCl concentrations of 6 
% and 10 % are not included here as we obtained a low survival of the cells. Such environmental 
conditions (cultivation at 30°C or incubation in a medium containing 2 % NaCl) increased the 
mRNA levels of fimP, specifying the major subunit of pil3, by approximately 30 and 23-fold, 
respectively, with respect to the highest expression (37-fold) at 37°C which represents the 
positive control where B. bifidum PRL2010 is piliated (Fig. 1). Temperatures closer to 30°C are 
commonly found in the upper regions of the human GIT (Kim, Kim et al. 2013), thus suggesting 
that an exposure of PRL2010 cells to such a temperature pre-adapts cells for their subsequent 
colonizat ion of the human gut. Furthermore, Western blot analyses using antibodies (Abpil3) that 
had been raised against the major subunit protein of pil3 loci, FimPPRL2010, were performed on 
PRL2010 cells grown using the identical range of incubation temperatures and NaCl 
concentrations described above. Clear signals representing a protein of 55.4 kDa were observed 
when crude extracts of PRL2010 cells, which had undergone cultivation at 30°C or in the 
presence of 2 % NaCl, were probed in Western blots using Abpil3 (Fig. 1). Interestingly, only the 
monomeric form of fimP was detected at 25°C while no apparent polymerizat ion into polymeric 
pili structures was observed (Fig. 1). The fact that the major pilin protein was expressed indicates 
that the polymerization of monomers into a complete pilus structure may readily occu r upon a 
temperature switch as has previously been noticed for pili of Enterococcus faecium (Hendrickx, 
Bonten et al. 2008). However, we cannot exclude the possibility that the polymerized form of 
fimP is not easily accessible and recognizable by the antibody compared to the monomeric form. 
qRT-PCR analyses demonstrated a transcription of the monomeric subunits approximately of 10 -
fold respect the positive control (37-fold) where B. bifidum PRL2010 is piliated. Higher 
molecular weight signals of above 100 kDa detected in each immunoblot image (Fig. 1) likely  
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represent the covalently linked polymers of FimP, a typical feature of sortase-dependent pili 
(Ton-That and Schneewind 2004, Telford, Barocchi et al. 2006, Turroni, Serafini et al. 2013).  
Other environmentally  relevant cues, such as fluctuations in pH and exposure to bile salts, may  
also influence pilus expression as described previously for other enteric organisms (Hendrickx, 
Bonten et al. 2008). Thus, transcription of the genes cluster encoding pil3 in B. bifidum PRL2010 
cells cult ivated in MRS broth displaying different level of acidity (pH) of 2 or 4, or concentration 
of bile salts of 0.5 %, was investigated at both mRNA and protein level by using qRT-PCR and 
Western blot approaches, respectively. Transcripts from fimP were detected for all pH values 
tested, with mRNA levels corresponding to fimP showing a considerable increase following 
cultivation of PRL2010 cells in MRS at pH 4 (41-fo ld) respect the positive control (37-fo ld) (Fig. 
1). The reference condition used involves PRL2010 cultures cultivated in MRS broth at 37°C 
without lysine, which is a condition that do not allow the production of pili sortase-dependent by 
PRL2010 cells (Turroni, Serafin i et al. 2013). Similarly, fimP mRNAs reaches a high amount at 
0.5 % of bile salts added to the substrate (27-fo ld) (Fig. 1). In order to simulate the gastric 
passage, we grew B. bifidum PRL2010 cells in presence of pancreatin as previously published 
(Serafin i, Strati et al. 2013). In th is growth condition the level of fimP t ranscripts increased 14-
fold. Furthermore, pilin proteins extracted from the same PRL2010 cultures used for qRT-PCR 
trials were assayed using specific Abpil3 antibody. Such Western blot analyses revealed a higher 
amount of major pilin subunits when PRL2010 cells were cult ivated in MRS broth at pH 4 or in  
the presence of 0.5 % bile salts as well as upon cell treatment with pancreatin  (Fig. 1). No  
relevant expression of pil2 locus has been detected under the tested conditions. 
Pili production of B. bifidum PRL2010 in response to co-cultivation with other gut 
organisms. In a previous study it has been shown that sortase-dependent pili of PRL2010 
mediate microb ial co-aggregation (Turroni, Serafini et al. 2013). Furthermore, sortase-dependent 
pili p lay a crucial role in  biofilm init iation and maturation in complex bacterial communities such 
as those encountered in the human oral cav ity [for a review see (Danne and Dramsi 2012)]. Thus, 
we were interested to explore if the expression of sortase-dependent pili of B. bifidum PRL2010 
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is influenced by the presence of other bacterial gut inhabitants such as B. breve 12L, B. 
adolescentis 22L, B. animalis subsp. lactis Bl12 (Milani, Duranti et al. 2013), which represent 
bifidobacterial species sharing a common ecological n iche, and L. paracasei LMG9192, o r by the 
eukaryotic organism S. cerevisiae BY4741. Evaluation of the transcription levels of individual 
genes of the pil2 and pil3 loci of B. bifidum PRL2010 upon co-cultivation of PRL2010 cells with 
these organisms, followed by extraction of RNA samples was assayed through qRT-PCR. 
Furthermore, possible enhancement or reduction of the cells density of PRL2010 as consequence 
of the co-cultivation with other gut organisms was monitored. As displayed in Fig. 2, no major 
effect in terms of variation of the cell density was noticed when PRL2010 was co -cultivated with 
the above mentioned organisms except for S. cerevisiae BY4741, which displays a slight 
enhancement of cell density upon co-cultivation with PRL2010 cells. Whereas, an increase of the 
mRNA levels of the major subunit-encoding gene of pil3 and pil2 by approximately eight and 
three-fold, respectively, was noticed when PRL2010 was co-cultivated with L. paracasei 
LMG9192. In the co-cultivation experiments of PRL2010 with B. breve 12L the enhancement of 
the major subunit-encoding gene of pil3 expression was about three-fold while the major subunit 
of pil2 does not appeared to be expressed (Fig. 3). No increase in expression was noticed, for the 
major subunit encoding gene of pil2 and pil3, when B. bifidum PRL2010 was co-cultivated with 
the other organisms here assayed (Fig. 3). Crude protein ext racts from the set of microb ial co-
cultivations displaying a remarkable expression of fimP gene, were also subjected to Western blot 
analysis using Abpil3. Clear signals representing a protein of 55.4 kDa were noticed in the case of 
association of PRL2010 with B. breve 12L or L. paracasei LMG9192 as compared with the 
control piliated PRL2010 cells (PRL2010 cultivated in MRSc plus lysine) (Fig. 3). Nevertheless, 
a faint signal was also noticed on protein extract from B. breve 12L, which may indicate a 
possible cross-reaction with the sortase-dependent pilus protein produced by this bacterium. In  
fact, in silico analyses of the genome sequences of this microorganism h ighlighted the existence 
of sortase-dependent pilus loci in  its chromosome (Bottacini et al., submitted ms), which suggests 
a cross-hybridization of Abpil3 with such extracellular structures. 
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Evaluation of the aggregation properties of B. bifidum PRL2010. As previously described, 
pili of PRL2010 are ab le to promote the co-aggregation of Lactococcus lactis expressing both 
Pil2PRL2010 and Pil3PRL2010 (Turroni, Serafin i et al. 2013). However, nothing is known about the 
putative role of pili of PRL2010 in driving aggregation with other bifidobacteria as we ll as other 
microorganis ms that share their ecological niche with PRL2010. Aggregation following co -
cultivation of B. bifidum PRL2010 together with a set of commensal bacteria  of the human gut 
(B. breve 12L, B. adolescentis 22L, B. animalis subsp. lactis Bl12, B. angulatum LMG11039, B. 
catenulatum LMG16992, B. gallicum DSM20093, B. longum subsp. infantis ACC15687, B. 
kashiwanohense DSM21854, B. longum subsp. longum NCC2705, B. pseudolongum subsp. 
pseudolongum LMG11571, L. paracasei LMG9192), o r the eukaryote S. cerevisiae BY4741, was 
evaluated as described in the Materials and Methods section and compared to non -pilated 
PRL2010 cells (reference condition). After five hours of incubation, B. bifidum PRL2010 cells 
showed an increase in aggregation (p<0.05) when co-incubated with B. angulatum LMG11039 
(5.4%) B. gallicum DSM20093 (27.1%), B. kashiwanohense DSM21854 (5.5%) and L. paracasei 
LMG9192 (5%) cells, with respect to the reference condition (Fig. 4). In all the other bacterial 
mixes the strength of co-aggregation estimated was lower than or equal to the auto-aggregation 
levels of PRL2010 (Fig. 4). These results were confirmed by the presence/absence of FimP in  the 
crude microbial ext racts of the above mentioned bacterial mixes through Western blot analyses 
(Fig. 4). When B. bifidum PRL2010 cells were co-cultivated with the organisms for which we 
noticed a high percentage of co-aggregation, a signal of 55.4 kDa was evident corresponding to 
the major p ilin subunit as well as higher bands suggesting the occurrence of a pilus unit 
polymerization under the conditions tested (Fig. 4).  
Evaluation of the change in aggregation by flow cytometry. Flow Cytometry (FCM) analysis 
revealed that the frequency of cell aggregates present in piliated B. bifidum PRL2010 cell 
suspension, and characterized by a wide range of FSC values measured (Fig. 5), was modified  
when piliated B. bifidum PRL2010 cells were in association with other microorganisms. While 
the FSC profile of the association between piliated PRL2010 cells and S. cerevisiae BY4741 
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cells (Fig. 5f) results to be the superimposition of the FSC profiles of each independent cell 
suspension, thus it was possible to distinguish the two populations. This was not the case of the 
FSC profiles for the other associations. In fact, when piliated PRL2010 cells were grown in  
association with L. paracasei LMG9192 or B. gallicum DSM20093 cells, the FSC profile o f the 
association indicated an increase or decrease of the frequency and/or dimension of cell 
aggregates if compared to those detected in piliated PRL2010 cells or B. gallicum DSM20093 
cells or L. paracasei LMG9192 cells alone (Fig. 5). Conversely, the FSC profile of piliated 
PRL2010 in association with B. kashiwanohense DSM21854 cells or with B. longum subsp. 
infantis ATCC15697 cells resembled those of strain DSM21854 and ATCC15697 alone, thus 
indicating a decrease of the frequency and/or dimension of cell aggregates as confirmed by phase 
contrast microscope observation (Fig. 5). FCM analyses clearly demonstrated that the co-
aggregates of piliated PRL2010 cells when placed together with cells of another gut organisms 
are disaggregated and are prone to a direct interaction between PRL2010 cells and cells of other 
gut associated micro-organisms. Such behaviour is essential to sustain microbe-microbe 
interaction in complex bacterial communities such as those encountered in the h uman gut.  
Conclusions 
Although pili have only recently been described in bifidobacteria (Foroni, Serafin i et al. 2011, 
Motherway, Zomer et al. 2011, Turroni, Serafini et al. 2013), very little is so far known about the 
environmental factors that trigger their expression in vivo, i.e. when bifidobacteria reside in their 
ecological n iches. In this study, we demonstrated for the first time how different growth  
conditions or environmental stresses simulating those encountered by bifidobacteria during their 
passage through the gastrointestinal tract (e.g., heat and acidic fluctuations) as well as during the 
establishment of bifidobacterial cells in the gut (e.g., osmotic stress and/or bile salt challenges) 
influence the expression bifidobacterial p ili sortase-dependent genes and consequently the 
synthesis of pili subunits. Considering that bifidobacteria are largely explo ited by food industries 
as health promoting bacteria it is crucial importance to develop reliable formulations that 
predispose the microbial cells to interact with the human host. Thus, pre-exposure of bacterial 
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cells to environmental conditions that may cause differential expression of key host -microbe 
effectors like p ili is important for the development of effective probiotic formulations.  
Here, we have also explored the putative role of sortase-dependent pili as key mediators for the 
physical interaction with other member of the human gut microb iota. We noticed that the level of 
expression of pil3 locus of B. bifidum PRL2010 is considerably enhanced upon co-cultivation of 
PRL2010 cells with L. paracasei and at lesser extent with B. breve 12L. We do not know if this 
enhancement in the synthesis of pili of PRL2010 is triggered by a quorum sensing stimulus or is 
dependent on the presence of capsular carbohydrates released in the environment by such gut 
microorganis ms. In fact, as previously noticed the expression of sortase-dependent pili by B. 
bifidum PRL2010 is influenced by the occurrence of complex carbohydrates in the media 
(Foroni, Serafin i et al. 2011). Also, sortase-dependent pili produced by PRL2010 cells may  
represent key appendages involved in the interaction with other bacteria through heterogeneous 
aggregation. Such observations reinforce the notion that sortase-dependent pili of bifidobacteria 
do not only support the interaction with the intestinal mucosa of the human intestine but are also 
pivotal for providing a physical bridge between a heterogeneous population of bacterial cells. In  
addition, we postulated that sortase-dependent pili are p laying a key role in modulating the 
microbe-microbe interaction through the development of hetero-aggregates between the members 
of complex microbial communities such as those found in the human intestine. 
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Table 1. Strains used in this study.  
 
 
 
 
 
 
 
 
Strains  References  
B. bifidum PRL2010 (Turroni, Bottacini et al. 2010) 
B. animalis subsp. lactis Bl12 (Milani, Duranti et al. 2013) 
B. breve 12L (Turroni, Foroni et al. 2011) 
B. adolescentis 22L (Turroni, Foroni et al. 2011) 
B. angulatum LMG11039 (Miyake, Watanabe et al. 1998) 
B. catenulatum LMG16992 (Scardovi and Crocian i 1974) 
B. gallicum DSM20093 (Miyake, Watanabe et al. 1998) 
B. longum subsp. infantis ATCC15697 (Sela, Chapman et al. 2008) 
B. kashiwanohense DSM21854 (Morita, Nakano et al. 2011) 
B. longum subsp. longum NCC2705 (Schell, Karmirantzou et al. 2002) 
B. pseudolongum subsp. pseudolongum LMG11571 (Miyake, Watanabe et al. 1998) 
L. paracasei LMG9192 (Collins, Phillips et al. 1989) 
S. cerevisiae BY4742 
Yeast genetic Stock Center 
(Berkeley, CA) 
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Legends 
Figure 1. Pili production of PRL2010 cultivated under different growth conditions. Panel a 
shows  relative transcription levels of pilus -encoding genes pil2 and pil3 of B. bifidum PRL2010 
cultures subjected to different stress conditions. BBPR_0282 encodes the minor subunit (fimQ), 
BBPR_0283 encodes the major subunit (fimP), and BBPR_0284 specifies the sortase of the pil3 
locus. BBPR_1707 encodes the major subunit (fimA), BBPR_1708 encodes the minor subunit 
(fimB), and BBPR_1709 specifies the sortase of the pil2 locus. The reference condition used 
involves PRL2010 cultures cultivated in MRS broth at 37°C without lysine, which is a condition 
that do not allow the production of pili sortase-dependent by PRL2010 cells (Turroni, Serafini et  
al. 2013). Panel b displays Western blot analyses of crude protein extracts of B. bifidum 
PRL2010 cultures previously exposed to different stressful conditions. Lane 1, negative control 
(MRS without lysin); lane 2, positive control (37°C in MRS plus lysin); lane 3, 30°C; lane 4, 
25°C; lane 5, oxgal 0.5 %; lane 6, pH 4; lane 7, NaCl at 2 %; lane 8, pancreatin. 
 
Figure 2. Growth of B. bifidum PRL2010 co-cu ltivated with other micro organisms. The 
histogram represents, through RT-PCR analyses, the genome copy number/ml broth of B. breve  
12L, B. adolescentis 22L, B. animalis subsp. lactis Bl12, S. cerevisiae BY4741, L. paracasei 
LMG9192 alone and co-cultivated with B. bifidum PRL2010. 
 
Figure 3. Modulation of the expression of sortase-dependent pili of B. bifidum PRL2010 upon 
co-cultivation with other bacteria. Panel a displays the relative transcription leve ls of pilus-
encoding genes pil2 and pil3 from B. bifidum PRL2010 upon co-cultivation with different 
organisms. Panel b shows Western blot analyses using crude extracts of PRL2010 cells upon co-
cultivation with various organisms. Lane 1, negative control consisting of the crude extracts of 
non-piliated B. bifidum PRL2010 cells; lane 2, crude extracts of B. breve 12L; lane 3, crude 
extracts of cultures consisting of B. bifidum PRL2010 co-cultivated with B. breve 12L; lane 4, 
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crude extracts of B. bi fidum PRL2010 co-cu ltivated with L. paracasei LMG9192; lane 5, crude 
extracts of L. paracasei LMG9192.  
Figure 4. Co-aggregation of B. bifidum PRL2010 cells with different gut organisms. The graph 
shows the comparison of co-aggregation ability of p iliated B. bifidum cells with other strains 
compared to the percentage of auto-aggregation of non-piliated PRL2010 cells grown alone. The 
level of auto-aggregation for the other organisms tested alone is also displayed. Above each pillar 
showing the co-aggregation level measured for the microbial mixture, the corresponding Western 
blot profile of the crude ext racts probed with Abpil3 is displayed. 
 
Figure 5. FCM analysis and phase contrast microscopic pictures of B. bifidum PRL2010 alone 
and in association with B. angulatum LMG11039, B. kashiwanohense DSM21854, B. longum 
subsp. infantis ATCC15697, L. paracasei LMG9192 and S. cerevisiae BY4741. FCM plots 
report the FSC parameter as area logarithmic signals (FSC-A). Dark lines refer to the FSC profile 
of PRL2010 cell suspension. Red lines referred to the FSC profile of the other microorganis ms 
alone. Blue lines refer to the FSC profile of cu lture associations between PRL2010 and one of the 
other microorganisms as indicated in the figure. Panel a shows PRL2010 alone. Panel b, d isplay 
the association between PRL2010 and B. gallicum DSM20093. Panel c depicts the association 
between PRL2010 and B. longum subsp. infantis ATCC15697. Panel d exh ibits the association 
between PRL2010 and B. kashiwanohense DSM21854. Panel e evidences the association 
between PRL2010 and L. paracasei LMG9192. Panel f shows the association between PRL2010 
and S. cerevisiae BY4741. All p ictures, except that represented in panel a referred to culture 
association.
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Abstract 
Bifidobacteria constitute one of the dominant groups of microorganisms colonizing the human 
gut of infants. Their ability to utilize various host-derived glycans as well as dietary 
carbohydrates has received considerable scientific attention. However, very  litt le is known about 
the role of fermented foods, such as kefir, or their constituent glycans, such as kefiran, as 
substrates for the growth of bifidobacteria and for the modulation of the expression of 
bifidobacterial host-effector molecules. Here, we show that Bifidobacterium bifidum PRL2010 
exhibits high growth performance among the bifidobacterial strains tested when cultivated on 
kefir and/or kefiran polymer. Furthermore, a 16S rRNA metagenomic approach revealed that the 
microbiota of kefir is modified upon the addition of PRL2010 cells to the kefir matrix. Finally, 
our results show that kefir and kefiran are able to influence the transcriptome of B. bifidum 
PRL2010 causing increased transcription of genes involved in the metabolism of d ietary glycans 
as well as genes that act as host-microbe effector molecules such as pili.  
 114 
 
1. Introduction 
Kefir is a fermented milk beverage that originated in Eastern Europe (Wouters, Ayad et al. 2002). 
It is a self-carbonated dairy product with a slightly acidic taste, yeasty flavor, creamy 
consistency, and low alcohol content (Marshall and Cole 1985, Garrote GL 2010, E (2005)). 
Many health benefits have been attributed to kefir, including the enhancement of the immune 
system and improvement of digestive health, as well as antimicrobial, antitumor, antiv iral, 
antimutagenic, and antioxidant activity (Otles, Cagind i et al. 2003, Santos, San Mauro et al. 
2003, Liu, Chen et al. 2005, Rodrigues, Carvalho et al. 2005, de LeBlanc, Matar et al. 2007, 
Vardjan, Lorbeg et al. 2013). Kefir is produced by the fermentation of milk with kefir grains. The 
grains contain a cocktail of microorganisms that co-exist in a complex symbiot ic relationship, 
and include species of lactic acid bacteria (e.g., lactobacilli, lactococci, leuconostoc, 
streptococci), yeasts, acetic acid bacteria and mycelia-fo rming fungi (Garbers I-M 2004, Vardjan, 
Lorbeg et al. 2013). Speciation of indiv idual microbes present in such a complex microbial 
consortium is complicated by the fact that some of the constituent microorganis ms cannot be 
grown on currently available synthetic growth media (Muyzer, de Waal et al. 1993, Wyder, 
Meile et al. 1999). 
Following the fermentation process the kefir grains can be recovered, reused, and cultivated, 
often over long periods. In addition to the value of the kefir-associated microbial community as a 
whole, specific strains isolated from kefir may have value as probiotics (Golowczyc, Gugliada et 
al. 2008), as kefir is considered an example of a probiotic mixture of bacteria and yeast (Simova, 
Beshkova et al. 2002). 
The exopolysaccharide (EPS) produced by the kefir microflo ra, named kefiran, is a  
heteropolymer (with a hexasaccharide repeated unit) containing glucose and galactose (Micheli, 
Uccelletti et al. 1999). Several health-promoting properties of kefiran, such as 
immunomodulation or ep ithelium protection, have been reported (Vinderola, Perdigon et al. 
2006, Medrano, Perez et al. 2008). In addition, EPS synthesized by kefir bacteria could act as a 
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fermentable substrate for other microorganisms in the kefir milk, modifying interactions among 
kefir populations. Within this context, there is a growing commercial interest to use kefir as a 
suitable food matrix for the supplementation with health-promoting bacteria. Here, we wanted to 
explore the interactions that may occur between kefir and kefiran, and common human gut 
residents such as bifidobacteria, and to investigate if these substrates modulate expression of 
specific host-responsive molecule effectors, e.g. pili (Ventura, Turroni et al. 2012, Turroni, 
Serafini et al. 2013). 
Bifidobacteria enjoy intensive commercial exp loitation by food industry due to the presumed 
health beneficial effects they exert on the human host (Masco, Huys et al. 2005). Various 
molecules, such as capsular polysaccharides and fimbriae/pili produced by bifidobacteria, are 
considered crucial in mediating host interactions and are believed to cover or protrude from the 
bacterial cell, thus being exposed to the external environment of the bacterial cell (Motherway, 
Zomer et al. 2011, Fanning, Hall et al. 2012, Ventura, Turroni et al. 2012, Turroni, Serafini et al. 
2013). However, the molecular mechanis ms underlying the presumed health -promoting activities 
of bifidobacteria, or the dietary compounds that may be responsible for driving the expression of 
the above-mentioned host-bifidobacterial responsive molecules are still largely unknown.  
Here, we assessed the possibility to utilize kefir as a substrate for the growth of bifidobacteria, 
with specific emphasis on the infant gut commensal Bifidobacterium bifidum PRL2010, serving 
as our bifidobacterial model (Turroni, Bottacini et al. 2010, Turroni, Strati et al. 2012, Serafin i, 
Strati et al. 2013, Turroni, Serafini et al. 2013). Furthermore, we have evaluated if the presence 
of PRL2010 cells influences the kefir bacterial microbiota using 16S rRNA gene metagenomic 
approach and explored the impact of kefir compounds on the transcriptome of B. bifidum 
PRL2010. 
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2. Materials and methods  
2.1. Bacterial  strains and growth conditions . 
Bifidobacterial strains used in this study are listed in Table 1, and were cult ivated in an anaerobic 
atmosphere (2.99 % H2, 17.01 % CO2 and 80 % N2) in a chamber (Concept 400, Ruskin) on De 
Man-Rogosa-Sharp (MRS) (Scharlau Chemie, Barcelona, Spain) supplemented with 0.05 % 
(w/v) L-cysteine hydrochloride (MRSc) and incubated at 37°C for 16 h. 
2.2. Kefir Grains.  
Kefir grains were sampled four t imes, once per month. Between two consecutive samplings, kefir 
grains were transferred daily and propagated at 23°C in pasteurized milk accord ing to a dairy 
routine protocol (Generoso, Wolf et al. 2005, Kok-Tas, Seydim et al. 2013). 
2.3. Growth of bifidobacteria in Kefir by Culture-Dependent Methods. 
 Kefir grains were incubated in sterile 10 % reconstituted skim milk at 23°C for 24 h. The grains 
were removed by filtration and the obtained fermented kefir milk was inoculated with 2 % of 
each strain to be tested (Table 1). In order to monitor the specific strain survival over the course 
of the kefir fermentation, kefir milk samples were first homogenized, 10 -fold serial dilutions 
were then prepared and appropriate dilutions were spread plated onto MRSc supplied with 50 
e, UK). Plates were incubated overnight anaerobically at  
37°C. In order to evaluate if bifidobacterial cells were still present in the kefir at the end of 
fermentation, ten colonies from each condition were randomly picked in MRS broth and 
incubated overnight anaerobically at 37°C. The strain identity was assayed by PCR using strain -
specific primers (Tab le 2).  
2.4. Purification and chemical analysis of Kefiran.  
Three different batches of fermented milk kefir, made by the same manufacturer, were purchased 
from the supermarket (stated carbohydrate, protein, and fat contents were 4 %, 3.8 % and 4.5 %, 
respectively). These fermented milks were used to isolate the EPS kefiran using a previously 
described procedure by Burns and co-workers (Burns, Vinderola et al. 2011). In short, series of 
glass flasks containing 40 g kefir were mixed with 8 ml of 60 % TCA solution (final TCA 12 %) 
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and vigorously stirred for 45 min at room temperature. Then, samples were centrifuged (10,000 x 
g, 4ºC, 30 min) to remove the surface layer of fat as well as the precipitated proteins and bacteria. 
The pH of the supernatants was increased with 10 M NaOH up to 4.5 and introduced in cellulose 
dialysis membranes (12-14 kDa MWCO, Sigma Chemical Co. St. Louis, MO, USA). Intensive 
dialysis was carried out against ultra-pure water at 4ºC during three days with two changes of 
water per day. Finally, dialysed samples were frozen at -80ºC and free-dried in the Freezemobile 
12L lyophilizer (VirTis, Thermo-Fisher Scientific, Madrid, Spain) to obtain the lyophilized  
power. The protein content of this powder, as determined by the BCA protein assay kit (Pierce, 
IL, USA), was 22.4±5.2%. The kefiran yield, as well as the distribution of molecular weight and 
radius of gyration of the polymer, in the lyophilized powder was determined by means of size 
exclusion chromatography (SEC) as previously described (Salazar, Prieto et al. 2009). An HPLC 
system from Waters (Milford, MA, USA) was used, which was composed of the Alliance 2690 
module in jector, the Photodiode Array PDA966 detector, and the Refract ive Index RI410 
detector. These detectors were coupled in series with the multiangle laser light scattering 
(MALLS) detector Dawn Heleos II (Wyatt Europe GmbH, Dembach, Germany). The analysis of 
data was achieved by the Astra V 5.3.4.19 software (Wyatt Europe). Then, 10 mg lyophilized  
powder was dissolved in 0.1 M NaNO3 and separated by chromatography using TSK-Gel G3000 
PWXL and TSK-Gel G5000 PWXL (Supelco-Sigma) columns placed in series and protected 
with a TSK-guard column. The same solution was used as the mobile phase and the separation 
took place at 40ºC at 0.45 ml/min flow rate for up to 60 min. The kefiran yield was calculated 
from the RI data using the corresponding regression equations (R2 ≥ 0.9999) obtained from 
dextran standards (Fluka-Sigma) of similar size (4.9x10
6
 Da and 2.7x10
5
 Da). The PDA detector 
set at 280 nm was used to check the absence of protein in the peaks corresponding to kefiran. The 
weight average molar mass (Mw) and the radius of gyration (Rw) were directly measured with 
the MALLS detector and used to calculate the coefficient  [ = (logRw/ log Mw)].  
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2.5. Growth of B. bifidum PRL2010 in kefiran-containing medium by Culture-Dependent 
Methods. 
 A pre-inoculum of PRL2010 was washed with PBS and resuspended in the same volume of 
carbohydrate-free MRSc (CF-MRSc) fo rmulated according to the composition of the Difco 
medium (BD, Biosciences, San Diego, CA) but without glucose. Then, B. bifidum PRL2010 was 
inoculated (2 %) in 10 ml of CF-MRSc containing 0.3 % (wt/vol) kefiran and incubated at 37ºC 
under anaerobic conditions. CF-MRSc and this medium supplemented with 0.3 % glucose were 
used as controls. To monitor the growth performance of PRL2010, bacterial counts were carried  
out by deep plating in MRSc agar following incubation under anaerobic conditions for 8 h, 24 h, 
48 h and 72 h at 37°C. St rain identity was assayed by PCR using specific primers based on the 
pil3 locus (Table 2) (Turroni, Serafini et al. 2013). Furthermore for each time point the pH value 
was measured. 
2.6. Kefir microbiota identification by 16S rRNA gene ampli fication. 
 DNA was extracted from kefir samples by acid guanidinium thiocyanate-phenol-chloroform 
extraction (Chirgwin, Przybyla et al. 1979, Chomczynski and Sacchi 1987, Boom, So l et al. 
1990). Part ial 16S rRNA gene sequences were amplified from extracted DNA using primer pair 
Probio_Uni and /Probio_Rev, which target the V3 region of the 16S rRNA gene sequence 
(Milani, Hevia et al. 2013). These primers were designed to include at their 5’ end one of the two  
adaptor sequences used in the Ion Torrent-sequencing library preparation protocol linking a 
unique Tag barcode of 10 bases to identify different samples. The PCR conditions used were 5 
min at 95°C, 35 cycles of 30 s at 94°C, 30 s at 55°C and 90 s at 72°C, followed by 10 min at 
72°C. Amplification was carried out using a Verity Thermocycler (Applied Biosystems). The 
integrity of the PCR amplicons was analyzed by electrophoresis on an Experion workstation 
(BioRad, UK).  
2.7. Ion Torrent PGM sequencing of 16S rRNA gene-based amplicons. 
PCR products derived from amplificat ion of specific 16S rRNA gene hypervariable regions were 
purified by electrophoretic separation on an 1.5 % agarose gel and the use of a  Wizard SV Gen  
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PCR Clean-Up System (Promega), fo llowed by an additional purification step involving the 
Agencourt AMPure XP DNA purification beads (Beckman Coulter Genomics GmbH, Bernried, 
Germany) in order to remove primer dimers. DNA concentration of the  amplified sequence 
lib rary was estimated through the Experion system (BioRad). From the concentration and the 
average size of each amplicon library, the amount of DNA fragments per microliter was 
calculated and lib raries for each run were diluted to 3E
9
 DNA molecules prior to clonal 
amplification. Emulsion PCR was carried out using the Ion OneTouch™ 200 Template Kit v2 
DL (Life Technologies) according to the manufacturer’s instructions. Sequencing of the 
amplicon libraries was carried out on a 316 chip using the Ion Torrent PGM system and 
employing the Ion Sequencing 200 kit (Life Technologies) according to the supplier’s 
instructions. Sequencing was performed at the DNA sequencing facility of GenProbio srl 
(www.genprobio.com). Following sequencing, the obtained individual sequence reads were 
filtered by the PGM software to remove low quality and polyclonal sequences. Sequences 
matching the PGM 3’ adaptor were also automatically trimmed. A ll PGM quality -approved, 
trimmed and filtered data were exported as  sff files. 
2.8. Sequence-based microbiota analysis . 
The sff files were processed using QIIME (Caporaso, Kuczynski et al. 2010). Quality control 
retained sequences with a length between 150 and 200 bp, mean sequence quality score >25, with 
truncation of a sequence at the first base if a low quality rolling 10 bp window was found 
Presence of homopolymers >7 bp, and sequences with mismatched primers were omitted. In 
order to calculate downstream diversity measures (alpha and beta diversity indices, Unifrac 
analysis), 16S rRNA Operat ional Taxonomic Units (OTUs) were defined at ≥ 97 % sequence 
homology. All reads were classified to the lowest possible taxonomic rank using QIIME and a 
reference dataset from the Ribosomal Database Project (Cole, Wang et al. 2009). OTUs were 
assigned using uclust (Edgar 2010). Further MEGAN analyses allowed the classification of reads 
down to species level (Huson, Mitra et al. 2011). The distance values based on population 
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profiles were calculated by Weighted uniFrac diversity values (Lozupone and Knight 2005). The 
range of distance is calculated between the values 0 and 1. 
2.9. RNA isolation.  
Total RNA was isolated using a previously described method (Turroni, Foroni et al. 2011). 
Briefly, cell pellets/tissue materials were resuspended in 1 ml of QUIAZOL (Qiagen, UK) and 
placed in a tube containing 0.8 g of glass beads (diameter, 106 μm; Sigma). The cells were lysed 
by shaking the mix on a BioSpec homogenizer at 4°C for 2 min (maximum setting). The mixture 
was then centrifuged at 12,000 rpm for 15 min, and the upper phase containing the RNA -
containing sample was recovered. The RNA sample was further purified by phenol extract ion 
and ethanol precipitation according to an established method (Sambrook 1989). The quality of 
the RNA was checked by analysing the integrity of rRNA molecules by Experion (BioRad).  
2.10. Microarray, description, labelling and hybridizations. 
Microarray analysis was performed with an oligonucleotide array based on the  B. bifidum 
PRL2010 genome: a total of 45,220 oligonucleotide probes of 60 bp in length were designed on 
1707 ORFs using eArray5.0 (Agilent Technologies). 5 Oligos were designed for each gene on a 
4x44k Agilent Microarrays (Agilent Technologies, Santa Clara, CA, USA) . Replicates were 
distributed on the chip at random, non-adjacent positions. A set of 152 negative control probes 
designed on phage and plant sequences were also included on the chip. Reverse transcription and 
amplification of 500 ng of total RNA was performed with ImProm-IITM Reverse Transcriptase 
(Promega, Madison, USA) according to the manufacturer’s instructions. Five µg of cDNA was 
then labeled with ULS Labeling kit with Cy5 or Cy3 (Kreatech, The Netherlands). For the 
purpose of the tiling array, samples containing kefir/kefiran cDNA was labeled with Cy5, while 
control samples were labeled with Cy3.  
Labeled cDNA was hybridized using the Agilent Gene Transcription hybridization kit (part  
number 5188-5242) as described in the Agilent Two-Color Microarray-Based Gene Transcription 
Analysis v4.0 manual (G4140-90050). Fo llowing hybrid ization, microarrays were washed in 
accordance with Agilent's standard procedures. 
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2.11. Microarray data acquisition and treatment.  
Fluorescence scanning was performed on an InnoScan 710 microarray scanner (Innopsys, 
France). Signal intensities for each spot were determined using Mapix5.5 software (Innopsys, 
Carbonne, France). Differential transcription tests were performed with the Cyber-T 
implementation of a variant of the t-test, as described previously (Bald i and Long 2001). A gene 
was considered differentially expressed between a test condition and a control when an 
expression ratio of 2 o r 0.5 relative to the result for the control was obtained with a 
corresponding P-value ≤ 0.001. 
2.12. Quantitative real-time reverse transcription PCR (qRT-PCR). 
The quality and integrity of the RNA were checked by Experion (Bio -Rad) analysis. cDNA was 
synthesized and purified using the iScript cDNA synthesis kit (Bio -Rad, Hercules, CA), 
according to the supplier’s instructions. qRT-PCR primers were used to amplify the genes 
encompassing the pilus loci, and the reference genes (atpD, rpoB and ldh). Criteria fo r primer 
design were based on a desired melting temperature ™ values between 58 and 60°C and 
amplicon size of approximately 100 base pairs. qRT-PCR was performed using the CFX96 
system (BioRad, CA, USA), fold change was evaluated through the estimat ion of the CT values 
with the aid of the CFX96 software (BioRad, CA, USA). Each PCR reaction mix contained the 
following: 12.5μl 2x SYBR SuperMix Green (BioRad, CA, USA), 1 μl of cDNA dilution, each  
of the forward and reverse primers at 0.5 μM and nuclease-free water was added to obtain a final 
volume of 20 μl. PCR products  were detected with SYBR Green fluorescent dye and amplified  
according to the following protocol: one cycle o f 95°C for 3 minutes, followed by 39 cycles of 
95°C for 5 s and 60°C for 20 s. Melting curve: 65°C to 95°C with increments of 0.5°C/s. In each 
run, negative controls (no cDNA) for each primer set were included. Fold change was calculated 
using the CFX96 software (BioRad).  
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2.13. Western Blotting. 
Overnight cultures were harvested by centrifugation and resuspended in lysis buffer (100 mM 
NaH2PO4, 10 mM Tris·Cl, 8 M urea pH 8). Th is bacterial cell suspension was then subjected to 
sonication using six 10 s bursts at 200–300 W with a 10 s cooling period between each burst. 
Bacterial cell envelopes were collected by centrifugation at 6,000 rpm for 2 minut es, the pellets 
were resuspended in 60 μl of PBS-lysis buffer containing SDS and β-mercaptoethanol, and 
boiled at 100°C for 15 min. Proteins were separated on a 10 % SDS -polyacrylamide gel and then 
transferred onto a nitrocellu lose membrane, which was blocked overnight at 4° C in Tris 
Buffered Saline (TBS) supplemented with 0.05 % Tween 20 (TBST) containing 5 % skim milk 
powder (blocking solution). Membranes were washed three times with TBST for 5 min and then 
incubated with the polyclonal antibody Abpil2 or Abpil3 (diluted 1:5000 in TBST) fo r two hours at 
RT. Immunoblots were then washed three times for 10 min with TBST fo llowed by 
immunodetection with IR Dye 680 Goat anti-rabbit for one hour. The nitrocellulose membrane 
(BioRad) was scanned using the Odyssey Infrared Imager at an intensity of 3.  
2.14. Microarray and nucleotide accession number. 
The transcriptional array data have been deposited in the GEO database under accession number 
GSE50506. The raw sequences reported in this article have been deposited in the NCBI Short  
Read Archive (SRA) (SRP029313).  
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3. Results and discussion 
3.1. Evaluation of growth capabilities of Bifidobacterium bifidum PRL2010 in kefir and in 
kefiran. 
We were interested in evaluating the growth capabilit ies  of different bifidobacterial strains (Table 
1) on kefir. Growth performances on fermented milk kefir were monitored by cell p lating of the 
strains to be tested on MRSc containing mupirocin, which is a selective antibiotic for the 
isolation of bifidobacteria (Serafini, Bottacini et al. 2011). In order to verify the identity of those 
bifidobacterial cells that had retained viability in the kefir upon cultivation, ten colonies were 
randomly p icked and strain identity was assayed by PCR using strain -specific primers, which  
were based on strain-specific genes (Table 2). In the case of PRL2010 the strain identity was 
verified by PCR using PRL2010-specific primers, which were designed based on the pil2 locus 
(Turroni, Serafini et al. 2013). As displayed in Figure 1, among the tested bifidobacteria, B. 
bifidum PRL2010 displayed one of the highest viability level, 2 x 10
6
 CFU/ml, following 24 hour 
of cultivation.  
Furthermore, we were interested in assessing the prebiotic features of kefiran, which is the 
heteropolysaccharide isolated from kefir samples on B. bifidum PRL2010. Growth performance 
of PRL2010 on CF-MRSc broth containing 0.3 % of kefiran as the sole carbon source, was 
monitored by cell plat ing at different time points, i.e., 8 h, 24 h, 48 h and 72 h. As displayed in 
Figure 1, upon 24 hours of incubation in kefiran, PRL2010 cells reached a cell density of 5.5 x 
10
8
 CFU/ml, suggesting that B. bifidum PRL2010 cells are capable of utilizing this kefir -derived 
glycan. It is worth mentioning that kefiran was obtained from fermented milk kefir by means of 
an extensive purificat ion process involving several and recurring chromatographic and dialysis 
steps. A table showing a representative SEC-MALLS chromatogram and the values of these 
parameters obtained for the purified kefiran are presented as supplementary material (Table S1 
and Figure S1).  
Moreover, the pH at all sampling points was measured, revealing an increase of acidity of the 
medium which was directly correlated to growth of B. bifidum PRL2010 (Fig. 1). 
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3.2. Evaluation of the kefir microbiota upon addition with PRL2010 cells.  
We were interested in assessing if the addition of B. bifidum PRL2010 cells to kefir would affect  
the overall composition of the microbiota of this substrate. Thus , we analyzed the microbiota 
composition of fermented milk kefir by means of 16S rRNA gene-based profiling using the Ion 
Torrent PGM technology. DNA was isolated from samples of kefir to which B. bifidum PRL2010 
had been added, and then incubated for 0 (p re-inoculum, reference condition), 12 and 24 hours. 
Partial 16S rRNA gene sequences were amplified from extracted DNA using primer pair 
Probio_Uni and /Probio_Rev, which had previously been used for similar studies (Milani, Hevia 
et al. 2013), and which targets the V3 region of the 16S rRNA gene sequence. 
In total, 246,427 sequence reads, representing 79,374, 111,206 and 55,847 reads for the reference 
condition (kefir), and test samples (kefir plus PRL2010) after 12 and 24 hours, respectively, were 
generated on the Ion Torrent PGM machine (Table 3). A large part of the diversity in these 
lib raries had been identified as demonstrated by the decrease in the rate of phylotype detection 
and the plateauing of the diversity index for the different samples analysed (Fig. 2). Clustering of 
de-noised high quality reads generated 2122 Operat ion Taxonomic Units (OTUs) that were 
taxonomically assigned down to genera level. Taxonomic allocation of these reads at phyla level 
revealed that Firmicutes were the dominant phyla comprising 90.35 % of the total sequences in 
kefir samples, a total of 15,453 kefir-associated reads were assigned to the Lactobacillaceae 
family (corresponding to 86.10 % of total assigned sequences) (Fig. 2). Furthermore, MEGAN 
analysis allowed the classificat ion of the obtained reads at a species level and showed a 
dominance of 16S rRNA reads harboring to Lactobacillus kefiranofaciens subsp. kefirgranum 
(86.10 %), Lactobacillus parakefiri (2.29 %), and L. delbrueckii subsp. sunki (10.43 %). 
Additionally, Clostridiaceae families accounted for just 0.2 %. The Proteobacteria phylum was a 
minor component of the kefir sample (0.03 %), while Bacteroidetes and Actinobacteria 
accounted for 0.1 % and 0.2 %, respectively. Among the Actinobacteria, members of the genus 
Bifidobacterium was detected at a low level (0.2 %) in the kefir sample, suggesting that 
bifidobacteria are not a major natural inhabitant of this environment. When B. bifidum PRL2010 
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was added to kefir, the levels of 16S rRNA reads corresponding to Actinobacteria and 
specifically of Bifidobacterium increased to 52.41 % after 12 hours, and to 22.47 % at 24 hours, 
with a decrease of the rate of reads belonging to Lactobacillus genus to 46.79 % and 76.95 %, 
respectively (Fig. 3). Weighted uniFrac diversity values based on population profiles (Lozupone 
and Knight 2005) at T0 and T24 are very similar, whereas it reaches the highest value (0.23) 
upon 12 hours. These data suggested that 12 hours after the inoculum B. bifidum becomes the 
predominant species but then decreases, and at T24 the init ial microbiota of the kefir is partially  
restored. 
3.3. Analysis of the global transcription profiling of PRL2010 cultivated in kefir and 
kefiran. 
We were further interested in obtaining insights into the B. bifidum PRL2010 genes whose 
transcription was affected when such bacterial cells were cultivated on kefir and kefiran. In order 
to explore the transcriptome of PRL2010 grown on kefir and kefiran -containing medium, we 
performed global transcription profiling using PRL2010-based microarrays hybridized with 
cDNA derived from the RNA samples of B. bi fidum PRL2010 cult ivated on these substrates.  
We isolated mRNA from B. bifidum PRL2010 cells collected from a culture of kefir and from 
PRL2010 cu ltivated on CF-MRSc p lus kefiran at 12 hours following inoculation.  
Genes were scored as being transcribed if their signal was identified in all hybridizat ion 
experiments, while also fulfilling additional signal strength criteria as outlined in the Materials 
and Methods section. A total of 40 or 19 genes were shown to be meeting these criteria upon 
grown in kefir or kefiran, respectively, and were thus considered to be transcribed under these in 
vitro conditions (Table 4 shows a selection of these genes). We used Cluster Orthologues Gene 
(COG) analysis in order to identify differentially transcribed genes that contribute to specific 
biological functions. As illustrated in Figure 4, carbohydrate metabolis m is one of the COG 
functions of PRL2010 most significantly affected by the cultivation of this microorganism on 
kefir or on kefiran. Compared with their abundance as a functional category in the genome, the 
transcriptomes of PRL2010 on kefir or on kefiran were somewhat enriched in functions related to 
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transport and metabolism of carbohydrates, which in the case of kefir is probably due to a 
response to the presence of this specific dietary glycan, whereas in the case of kefiran is due to its 
structure. In fact, this exopolysaccharide consists of approximately equal proportions of galactose 
and glucose residues (Generoso, Wolf et al. 2005). This can explain the observed high level of 
transcription of glycoside hydrolase-encoding gene, such as the predicted -galactosidase-
specifying gene BBPR_0482 (Table 4).  
3.4. qRT-PCR analyses.  
DNA loci such as the sortase-dependent pili-encoding pil1 (ORF1707-1709) and pil3 (ORF0282-
0284), which have previously been described to be pivotal in the interaction with the host 
(Turroni, Serafin i et al. 2013), were not represented on the DNA microarray that we used. Thus, 
we decided to investigate if these genes were (differentially) transcribed during growth of B. 
bifidum PRL2010 cells on kefir or kefiran using a qRT-PCR approach. Interestingly, 
BBPR_0283, encoding the major subunit of pil3, FimP, was shown to be transcribed 250-fold  
higher in kefir as compared with the reference condition (PRL2010 on MRSc) (Fig. 5). A similar 
transcription pattern was noticed when B. bifidum PRL2010 cells were cultivated on CF-MRSc 
plus kefiran, BBPR_0282, which encodes the minor subunit of pil3, and which was shown to be 
transcribed 30-fo ld higher with respect to the reference condition. (Fig. 5). In contrast, the genes 
spanning the pil1 locus did not appear to be transcribed under these conditions (i.e. growth in  
kefir or kefiran-containing medium).  
3.5. Western blotting analyses . 
Furthermore, Western blot analysis using antibodies Abpil3 that had been raised against the major 
subunit protein of the pil3 locus, FimP (specified by BBPR_0283), was performed on PRL2010 
cells that had been collected upon cultivation on kefir or on kefiran for 12 h. We decided to use 
this particular time point as this coincided with the highest level of transcription of BBPR_0283. 
Clear signals representing a protein of 55.43 kDa were noticed in  both conditions, even if at  
lower intensity than that identified for PRL2010 cells cultivated in MRSc plus lysine (positive 
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control) (Turroni, Serafini et al. 2013) (Fig. 5). In fact, as previously described the presence of 
lysine in the medium stimulated the production of sortase dependent pili by PRL2010 cells 
(Turroni, Serafin i et al. 2013). Whereas, as previously noticed PRL2010 does not produce any 
pili-like structures when cultivated on simple MRS substrate (without lysine) (Turroni, Serafini 
et al. 2013). Thus, we can argue that kefir and kefiran are important growth substrates that can be 
employed in order to modulate the expression of structures such as sortase-dependent pili that are 
known to be involved in host-microbe interaction (Turroni, Serafini et al. 2013). 
4. Conclusions 
In this study, growth performance of bifidobacterial strains from human gut origin was tested, 
revealing that B. bifidum PRL2010, which was previously shown to utilize different host glycans 
such as mucin and human milk oligosaccharides (Turroni, Bottacini et al. 2010, Turroni, Milani 
et al. 2011), is also able to utilize d ietary glycans such as kefiran. Also, our 16S rRNA -based 
metagenomics analyses highlight that PRL2010 is able to (temporarily) colonize kefir milk, 
thereby reducing the levels of other kefir microbiota members such as lactobacilli. This clearly  
suggests the existence of nutrient competition that may be linked to a different efficiency in the 
uptake of dietary glycans as well as by a diverse repertoire of extracellu lar enzymes involved in 
the breakdown of these carbohydrates. Furthermore, the kefir matrix was shown to modulate the 
expression of particular PRL2010 genes such as sortase-dependent pili, which have previously 
been demonstrated to play a pivotal role in host-interaction. Thus, particular food substrates like 
kefir may be used for the administration of bifidobacteria to humans and may represent a 
valuable food matrix to pre-adapt bifidobacterial cells to the host in order to enhance the effects 
of the probiotic admin istration.  
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Table 1. Bacterial strains used in this study.  
 
 
Strains Ecological 
origin 
References 
B. bifidum PRL2010 Infant stool  (Turroni, Bottacini et al. 2010) 
B. animalis subsp. lactis Bl12 Human intestine  (Milani, Duranti et al. 2013) 
B. breve 12L Human milk (Turroni, Foroni et al. 2011) 
B. adolescentis 22L Human milk (Turroni, Foroni et al. 2011) 
B. longum subsp. longum 296B Infant stool 
sample 
(Serafini, Strati et al. 2013) 
B. longum subsp. infantis 
ATCC15697 
Infant intestine (Mattarelli, Bonaparte et al. 
2008) 
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Table 2. Strain specific primers  
Primer Sequence (5’-3’) 
Targeted 
ORF/gene 
Organism 
BLAC1485Fw CGGTCATCCAGGTCGATACT BLAC1485 
B. animalis subsp. 
lactis Bl12 
BLAC1485Rv  CACGGTATATGTGCGGTCAG BLAC1486 
B. animalis subsp. 
lactis Bl12 
BAD_PilV_Fw GAGGTATTGGTGGCGATTGT 22L_0586 B. adolescentis 22L 
BAD_PilV_Rv  GGATGGCGCAGAAGTATGAT 22L_0586 B. adolescentis 22L 
B.inf_101Fw GATGTGCTTCATGACCTTGG B.lon 0101 
B.longum subsp. 
infantis ATCC15697 
B.inf_101Rv AACCGACGTAGTCGGAGATG B.lon 0101 
B.longum subsp. 
infantis ATCC15697 
BR12L_105Fw CCGAAGTTCCAGTTGACCAT Br_Milk_0105 B. breve 12L 
BR12L_105Rv  GTTCTTCGCGTTCCAGATGT Br_Milk_0105 B. breve 12L 
BBP0283Fw CACGGTGGAAAACAACCTGA  BBP0283 B. bifidum PRL2010 
BBP0283 Rv  GGCGTTGTAGGTGATGGTGA  BBP0283 B. bifidum PRL2010 
BiLon-1 TTCCAGTTGATCGCATGGTC 16S rRNA  
B. longum subsp. 
longum 296B 
BiLon-2 GGGAAGCCGTATCTCTACGA  16S rRNA  
B. longum subsp. 
longum 296B 
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Table 3. Quantitative data of the 16S rRNA gene sequence datasets used in this study.  
 
 
 
 
 
Sample Number 
of reads  
Number of reads removed because of: 
Final 
read 
number 
Reduced by (% ) 
Outside 
bounds 
(140-
400) 
Ambiguous 
bases 
Mean 
quality 
<15 
Homopolymer 
runs 
>7bp 
Primer 
mismatch 
>1 
Low 
quality 
window 
truncation 
results in 
<140bp 
T0 121162 19900 0 0 48 11213 10606 79374 34.5 
T12 155120 24212 0 0 241 9544 9909 111206 28.30 
T24 82142 11251 0 0 49 9498 5491 55847 32.01 
TOTAL 358424 
      
246427 31.24 
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Table 4. Selected transcripts up-regulated in cell cultivated on fermented milk kefir or kefiran-containing CF-MRSc compared to B. 
bifidum PRL2010 cells grown in MRSc. 
  Gene Product Fold change p-value 
K
e
fi
r
 
BBPR_0379 Endo-1,4-beta-xylanase 2.270 2.48E-04 
BBPR_0666 Two-component response regulator 2.310 1.93E-05 
BBPR_0854 ABC-type uncharacterized transport system. ATPase component 2.110 3.96E-03 
BBPR_1202 Solute-binding protein of ABC transporter system 2.326 2.01E-04 
BBPR_1283 Two component system histidine kinase 2.277 3.97E-04 
BBPR_1399 Glucose uptake protein 2.221 4.85E-04 
BBPR_1436 Response regulator of two-component system 2.642 5.67E-04 
BBPR_1714 Bgl1 Beta-g lucosidase 2.566 3.36E-04 
BBPR_1717 PTS system, cellobiose-specific component IIC 2.030 2.50E-04 
K
e
fi
r
a
n
 
BBPR_0031 PTS system, lactose/cellobiose-specific IIB component 2.587 3.01E-05 
BBPR_0239 PTS system, glucose-specific IIA component 2.061 2.65E-05 
BBPR_0362 Permease protein of ABC transporter system 2.255 1.46E-05 
BBPR_0363 Permease protein of ABC transporter system 3.015 4.15E-05 
BBPR_0482 LacZ Beta-galactosidase 2.471 1.99E-05 
BBPR_0517 Linoleic acid isomerase 2.924 4.43E-05 
BBPR_0562 Fructokinase 2.117 3.27E-05 
BBPR_0563 N-acetylglucosamine repressor 2.073 8.20E-05 
BBPR_1529 NagZ Beta-N-acetylhexosaminidase 3.702 3.72E-05 
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LEGENDS 
Fig. 1. Panel a: Growth performance of different bifidobacterial strains on kefir after 24 hours. 
Panel b displays the decrease of the pH of the media of the B. bifidum PRL2010 on kefiran, 
MRSc with glucose, MRSc w/o carbon source at 8, 24, 48, 72 hours. Panel c showes the growth 
(CFU/ml) of the B. bifidum PRL2010 on kefiran, MRSc with glucose, MRSc w/o carbon source 
at 8, 24, 48, 72 hours. The data represent the means of at least two independent experiments 
conducted in duplicate. The vertical bars indicate standard deviations. 
Fig. 2. Microbial composition of kefir grains. Panel a shows the diversity at phylum level of kefir 
milk microb iota, expressed as percentage of the total reads sequenced, at 0, 12 and 24 hours after 
inoculation of B. bifidum PRL2010. Bar shading represents the relative proportion of assignable 
tags present in each sample. Panel b displays rarefaction curves generated for 16S rRNA gene 
sequences using the Chao1 index.  
Fig. 3. Microbial diversity of kefir milk (at species level) before and after (two time points) 
addition of B. bifidum PRL2010. Weighted uniFrac diversity values based on population profiles 
are shown on the arrows of the pie chart. 
Fig. 4. Functional analysis according to COG categories  of B. bifidum PRL2010 genes 
transcribed upon cultivation on kefir or kefiran as determined by global transcription profiling. 
For each category, the black bar represents the percentage of genes in that category as detected in 
the sequenced genome of PRL2010 (Turroni, Bottacini et al. 2010). The other bar shows the 
percentages of genes transcribed upon growth on kefir (grey bar) or kefiran -containing medium 
(white bar) that belong to a particular category. The percentage was calculated as the percentage 
of transcribed genes belonging to the indicated COG category with respect to all transcribed 
genes.  
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Fig. 5. Relative transcription levels of pilus-encoding genes from B. bifidum PRL2010 upon 
cultivation in kefir and on CF-MRSc supplemented with kefiran assayed by qRT-PCR analysis 
(panels a and b, respectively) and Western blotting analysis (panel c). The histograms indicate 
the relative amounts of the pili mRNAs for the specific samples versus growth in MRSc 
supplemented with glucose as unique carbon source. In each panel, the ORF numbering indicates 
the gene code. The value on the y-axes represents the fold change relative to reference genes as 
indicated in the materials and method section. Results are shown as mean-standard deviation 
(SD) of triplicate analysis. Panel c shows Western blot analyses of PRL2010 cell extracts 
cultivated under different substrates probed with Abpil3. B. bifidum PRL2010 grown on: MRSc 
without lysine (lane 1); kefir (lane 2); CF-MRSc-kefiran (lane 3) and MRSc with lysine (lane 4).  
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10. Conclusions 
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10.1 Physiological characterization of B. bifidum PRL2010 
The first part of this thesis elucidates  the features of B. bifidum PRL2010, as a key member of the 
human gut microb iota. 
In the chapter 3 it was showed variable levels of susceptibility to mupirocin in bifidobacteria. 
These data are important for effective selection protocols for isolation as well as enumeration of  
bifidobacteria based on antibiotic inclusion in selective media.  Furthermore, it was investigated 
the genetic basis of resistance to mupirocin in b ifidobacteria and showed how this is conferred by 
the product encoded by the ileS gene. This gene cloned in a mupirocin-sensitive Escherichia coli 
strain, has showed how a particular amino acid residue, tyrosine, in the targeted enzyme (IleS)  
may be responsible for the high level of mupirocin resistance observed in bifidobacteria.  
Data presented in the chapter 4, show that B. bifidum PRL2010 possesses several features 
sustaining its adaptation to the human gut. The strong adhesive behavior displayed by PRL2010 
cells may thus reflect its ecological potential with in the highly competitive environment  of the 
human gut. In fact, the capabilit ies of an enteric bacterium to adhere to the intestinal mucosa is 
consequently linked to its abilit ies to stably colonize and persist in the intestine, and  therefore 
preventing the establishment of enteric pathogens.  
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10.2 Novel methods for transformation and genetic manipulation 
Molecular studies of Bifidobacterium are severely hampered by the absence of effective genetic 
tools, including efficient transformat ion protocols. In chapter 5 of this thesis it was described the 
development of a protocol for efficient and reproducible genetic transformation of B. bifidum 
PRL2010 by electroporation. The efficiency of transformation achieved in this study (10
4
 
UCF/µg) is sufficiently h igh for cloning purposes but it is not yet high enough for site-directed 
mutagenesis (O'Connell Motherway, O'Driscoll et al. 2009). 
10.3 Molecular validation of host-microbe effector molecules such as pili 
The fulcrum of the whole thesis is to investigate and to characterize candidate genes involved in 
the interaction between the bifidobacteria and the human host. Pili are involved in the 
attachment/colonization of members of the human microbiota to host tissues . However, very little  
is known about their occurrence in b ifidobacteria.  
Chapter 6 provides the first morphological evidence of pili-like structures decorating the cell 
surface of various bifidobacterial species. It further investigates the genetic organization and 
transcriptional profiling of the bifidobacterial p ilus in response to different growth substrates. In 
the chapter 7 it was elucidated the function of sortase-dependent pili in bifidobacteria. Like in  
other Gram-positive organisms, such as C. diphtheriae and Actinomyces spp. (Ton-That and 
Schneewind 2003, Mishra, Wu et al. 2010), in B. bifidum PRL2010, sortase-dependent pili are 
crucial for bacterial adherence to host cells. They may influence mucosal immune responses , in a 
similar scenario previously described for other human gut commensals  such as lactobacilli 
(Kankainen, Pau lin et al. 2009, von Ossowski, Reunanen et al. 2010).  
Moreover in chapter 8 it was investigated the expression and the modulation of pili sortase-
dependent genes of B. bifidum PRL2010 in response to the stress conditions simulating those 
encountered by bifidobacteria during their passage through the gastrointestinal tract (e.g., heat 
and acidic stresses) as well as during the establishment of bifidobacterial cells in the gut (e.g., 
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osmotic stress as well as bile salt challenges). It was investigated the putative role of sortase-
dependent pili in the interaction with other member of the human gut microbiota.  
The results here presented reinforce the notion that sortase-dependent pili of bifidobacteria might 
supporting the interaction with the other commensal of the GIT through the development of 
hetero-aggregates between the members of complex microbial communities such as those found 
in the human intestine. 
In the last chapter of this thesis it was investigated the prebiotic role of fermented foods, such as 
kefir, and their constituent glycans, such as kefiran, as substrates for the growth of bifidobacteria 
and for the modulation of the expression of pili. It has been shown that kefir and kefiran are able 
to influence the transcriptome of B. bifidum PRL2010, by increasing the transcription of genes 
involved in the metabolism of dietary glycans as well as genes that act as host -microbe effector 
molecules such as pili. The complex food matrix of kefir may be used for the supplementation of 
bifidobacteria to humans and may represent a medium to pre-adapt bifidobacterial cells to the 
host in order to enhance the effects of the probiotic admin istration. 
Considering that bifidobacteria are largely exp loited by food industries as health promoting 
bacteria, it is crucial to develop appropriated formulation to predispose microb ial cells to interact 
with the human host.  
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